<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-08-01" modified="2017-05-10" version="227">
<accession>P07949</accession>
<accession>A8K6Z2</accession>
<accession>Q15250</accession>
<accession>Q9BTB0</accession>
<accession>Q9H4A2</accession>
<name>RET_HUMAN</name>
<protein>
<recommendedName>
<fullName>Proto-oncogene tyrosine-protein kinase receptor Ret</fullName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Cadherin family member 12</fullName>
</alternativeName>
<alternativeName>
<fullName>Proto-oncogene c-Ret</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>Soluble RET kinase fragment</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Extracellular cell-membrane anchored RET cadherin 120 kDa fragment</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">RET</name>
<name type="synonym">CDHF12</name>
<name type="synonym">CDHR16</name>
<name type="synonym">PTC</name>
<name type="synonym">RET51</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT CYS-982</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1989" name="Oncogene" volume="4" first="805" last="806">
<title>Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence.</title>
<authorList>
<person name="Takahashi M."/>
</authorList>
<dbReference type="PubMed" id="2660074"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-280 (ISOFORMS 1/2)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1988" name="Oncogene" volume="3" first="571" last="578">
<title>Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.</title>
<authorList>
<person name="Takahashi M."/>
<person name="Buma Y."/>
<person name="Iwamoto T."/>
<person name="Inaguma Y."/>
<person name="Ikeda H."/>
<person name="Hiai H."/>
</authorList>
<dbReference type="PubMed" id="3078962"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 255-1114 (ISOFORM 1)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1987" name="Mol. Cell. Biol." volume="7" first="1378" last="1385">
<title>ret transforming gene encodes a fusion protein homologous to tyrosine kinases.</title>
<authorList>
<person name="Takahashi M."/>
<person name="Cooper G.M."/>
</authorList>
<dbReference type="PubMed" id="3037315"/>
<dbReference type="DOI" id="10.1128/MCB.7.4.1378"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 588-1063 (ISOFORM 2)</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH TRIM27</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1989" name="Oncogene" volume="4" first="789" last="794">
<title>Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing.</title>
<authorList>
<person name="Ishizaka Y."/>
<person name="Ochiai M."/>
<person name="Tahira T."/>
<person name="Suhimura T."/>
<person name="Nahao M."/>
</authorList>
<dbReference type="PubMed" id="2734021"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 713-1114 (ISOFORM 1)</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH GOLGA5</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1989" name="Oncogene" volume="4" first="1415" last="1415">
<authorList>
<person name="Ishizaka Y."/>
<person name="Ochiai M."/>
<person name="Tahira T."/>
<person name="Suhimura T."/>
<person name="Nahao M."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1990" name="Cell" volume="60" first="557" last="563">
<title>PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.</title>
<authorList>
<person name="Grieco M."/>
<person name="Santoro M."/>
<person name="Berlingieri M.T."/>
<person name="Melillo R.M."/>
<person name="Donghi R."/>
<person name="Bongarzone I."/>
<person name="Pierotti M.A."/>
<person name="Della Porta G."/>
<person name="Fusco A."/>
<person name="Vecchio G."/>
</authorList>
<dbReference type="PubMed" id="2406025"/>
<dbReference type="DOI" id="10.1016/0092-8674(90)90659-3"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 713-1114 (ISOFORM 1)</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH CCDC6</scope>
<source>
<tissue>Thyroid papillary carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Oncogene" volume="19" first="4236" last="4242">
<title>RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma.</title>
<authorList>
<person name="Corvi R."/>
<person name="Berger N."/>
<person name="Balczon R."/>
<person name="Romeo G."/>
</authorList>
<dbReference type="PubMed" id="10980597"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203772"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 713-770 (ISOFORMS 1/2)</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH PCM1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="4388" last="4393">
<title>The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas.</title>
<authorList>
<person name="Klugbauer S."/>
<person name="Rabes H.M."/>
</authorList>
<dbReference type="PubMed" id="10439047"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202824"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH TRIM33 AND TRIM24</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="J. Clin. Endocrinol. Metab." volume="85" first="3898" last="3907">
<title>Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins.</title>
<authorList>
<person name="Salvatore D."/>
<person name="Barone M.V."/>
<person name="Salvatore G."/>
<person name="Melillo R.M."/>
<person name="Chiappetta G."/>
<person name="Mineo A."/>
<person name="Fenzi G."/>
<person name="Vecchio G."/>
<person name="Fusco A."/>
<person name="Santoro M."/>
</authorList>
<dbReference type="PubMed" id="11061555"/>
<dbReference type="DOI" id="10.1210/jcem.85.10.6882"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1015 AND TYR-1062</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="14213" last="14224">
<title>Identification of RET autophosphorylation sites by mass spectrometry.</title>
<authorList>
<person name="Kawamoto Y."/>
<person name="Takeda K."/>
<person name="Okuno Y."/>
<person name="Yamakawa Y."/>
<person name="Ito Y."/>
<person name="Taguchi R."/>
<person name="Kato M."/>
<person name="Suzuki H."/>
<person name="Takahashi M."/>
<person name="Nakashima I."/>
</authorList>
<dbReference type="PubMed" id="14711813"/>
<dbReference type="DOI" id="10.1074/jbc.M312600200"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-806; TYR-809; TYR-900; TYR-905; TYR-981; TYR-1015; TYR-1062; TYR-1090 AND TYR-1096</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Mutat. Res." volume="527" first="81" last="90">
<title>Novel tumorigenic rearrangement, Delta rfp/ret, in a papillary thyroid carcinoma from externally irradiated patient.</title>
<authorList>
<person name="Saenko V."/>
<person name="Rogounovitch T."/>
<person name="Shimizu-Yoshida Y."/>
<person name="Abrosimov A."/>
<person name="Lushnikov E."/>
<person name="Roumiantsev P."/>
<person name="Matsumoto N."/>
<person name="Nakashima M."/>
<person name="Meirmanov S."/>
<person name="Ohtsuru A."/>
<person name="Namba H."/>
<person name="Tsyb A."/>
<person name="Yamashita S."/>
</authorList>
<dbReference type="PubMed" id="12787916"/>
<dbReference type="DOI" id="10.1016/S0027-5107(03)00056-3"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH TRIM27</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="6280" last="6287">
<title>The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins.</title>
<authorList>
<person name="Iervolino A."/>
<person name="Iuliano R."/>
<person name="Trapasso F."/>
<person name="Viglietto G."/>
<person name="Melillo R.M."/>
<person name="Carlomagno F."/>
<person name="Santoro M."/>
<person name="Fusco A."/>
</authorList>
<dbReference type="PubMed" id="16778204"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-0228"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-905; TYR-1015 AND TYR-1062</scope>
<scope>DEPHOSPHORYLATION AT TYR-905; TYR-1015 AND TYR-1062 BY PTPRJ</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="Bioorg. Med. Chem. Lett." volume="17" first="5886" last="5893">
<title>The discovery of substituted 4-(3-hydroxyanilino)-quinolines as potent RET kinase inhibitors.</title>
<authorList>
<person name="Graham Robinett R."/>
<person name="Freemerman A.J."/>
<person name="Skinner M.A."/>
<person name="Shewchuk L."/>
<person name="Lackey K."/>
</authorList>
<dbReference type="PubMed" id="17884497"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2007.07.104"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="29230" last="29240">
<title>Sorafenib functions to potently suppress RET tyrosine kinase activity by direct enzymatic inhibition and promoting RET lysosomal degradation independent of proteasomal targeting.</title>
<authorList>
<person name="Plaza-Menacho I."/>
<person name="Mologni L."/>
<person name="Sala E."/>
<person name="Gambacorti-Passerini C."/>
<person name="Magee A.I."/>
<person name="Links T.P."/>
<person name="Hofstra R.M.W."/>
<person name="Barford D."/>
<person name="Isacke C.M."/>
</authorList>
<dbReference type="PubMed" id="17664273"/>
<dbReference type="DOI" id="10.1074/jbc.M703461200"/>
</citation>
<scope>ENZYME REGULATION BY SORAFENIB</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="J. Med. Chem." volume="51" first="7777" last="7787">
<title>Synthesis, modeling, and RET protein kinase inhibitory activity of 3- and 4-substituted beta-carbolin-1-ones.</title>
<authorList>
<person name="Cincinelli R."/>
<person name="Cassinelli G."/>
<person name="Dallavalle S."/>
<person name="Lanzi C."/>
<person name="Merlini L."/>
<person name="Botta M."/>
<person name="Tuccinardi T."/>
<person name="Martinelli A."/>
<person name="Penco S."/>
<person name="Zunino F."/>
</authorList>
<dbReference type="PubMed" id="19053769"/>
<dbReference type="DOI" id="10.1021/jm8007823"/>
</citation>
<scope>ENZYME REGULATION BY 3- AND 4-SUBSTITUTED BETA-CARBOLIN-1-ONES</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="J. Neurosci." volume="28" first="8789" last="8800">
<title>CD2AP and Cbl-3/Cbl-c constitute a critical checkpoint in the regulation of ret signal transduction.</title>
<authorList>
<person name="Tsui C.C."/>
<person name="Pierchala B.A."/>
</authorList>
<dbReference type="PubMed" id="18753381"/>
<dbReference type="DOI" id="10.1523/JNEUROSCI.2738-08.2008"/>
</citation>
<scope>INTERACTION WITH CD2AP</scope>
<scope>MUTAGENESIS OF LYS-758</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="J. Clin. Endocrinol. Metab." volume="94" first="2571" last="2578">
<title>The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability.</title>
<authorList>
<person name="Vargiolu M."/>
<person name="Fusco D."/>
<person name="Kurelac I."/>
<person name="Dirnberger D."/>
<person name="Baumeister R."/>
<person name="Morra I."/>
<person name="Melcarne A."/>
<person name="Rimondini R."/>
<person name="Romeo G."/>
<person name="Bonora E."/>
</authorList>
<dbReference type="PubMed" id="19366855"/>
<dbReference type="DOI" id="10.1210/jc.2008-1980"/>
</citation>
<scope>INTERACTION WITH AIP</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="J. Pediatr. Surg." volume="44" first="1904" last="1912">
<title>Transcriptional regulation of RET by Nkx2-1, Phox2b, Sox10, and Pax3.</title>
<authorList>
<person name="Leon T.Y.Y."/>
<person name="Ngan E.S.W."/>
<person name="Poon H.-C."/>
<person name="So M.-T."/>
<person name="Lui V.C.H."/>
<person name="Tam P.K.H."/>
<person name="Garcia-Barcelo M.M."/>
</authorList>
<dbReference type="PubMed" id="19853745"/>
<dbReference type="DOI" id="10.1016/j.jpedsurg.2008.11.055"/>
</citation>
<scope>INDUCTION BY NKX2-1; PHOX2B; SOX10 AND PAX3</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-696</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Neuron" volume="64" first="773" last="776">
<title>RETouching upon mechanoreceptors.</title>
<authorList>
<person name="Ma Q."/>
</authorList>
<dbReference type="PubMed" id="20064382"/>
<dbReference type="DOI" id="10.1016/j.neuron.2009.12.014"/>
</citation>
<scope>FUNCTION IN DEVELOPMENT OF MECHANORECEPTORS</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="Endocr. Rev." volume="31" first="578" last="599">
<title>The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors.</title>
<authorList>
<person name="Ye L."/>
<person name="Santarpia L."/>
<person name="Gagel R.F."/>
</authorList>
<dbReference type="PubMed" id="20605972"/>
<dbReference type="DOI" id="10.1210/er.2009-0031"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>REVIEW ON KINASE INHIBITORS</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Eur. J. Med. Chem." volume="45" first="2919" last="2927">
<title>Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3-thienyl)nicotinonitrile scaffold.</title>
<authorList>
<person name="Brandt W."/>
<person name="Mologni L."/>
<person name="Preu L."/>
<person name="Lemcke T."/>
<person name="Gambacorti-Passerini C."/>
<person name="Kunick C."/>
</authorList>
<dbReference type="PubMed" id="20409618"/>
<dbReference type="DOI" id="10.1016/j.ejmech.2010.03.017"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Front. Horm. Res." volume="38" first="127" last="138">
<title>Functional role of the RET dependence receptor, GFRa co-receptors and ligands in the pituitary.</title>
<authorList>
<person name="Garcia-Lavandeira M."/>
<person name="Diaz-Rodriguez E."/>
<person name="Garcia-Rendueles M.E."/>
<person name="Rodrigues J.S."/>
<person name="Perez-Romero S."/>
<person name="Bravo S.B."/>
<person name="Alvarez C.V."/>
</authorList>
<dbReference type="PubMed" id="20616503"/>
<dbReference type="DOI" id="10.1159/000318502"/>
</citation>
<scope>FUNCTION IN PITUITARY</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="J. Clin. Endocrinol. Metab." volume="95" first="E342" last="E346">
<title>RET-mediated cell adhesion and migration require multiple integrin subunits.</title>
<authorList>
<person name="Cockburn J.G."/>
<person name="Richardson D.S."/>
<person name="Gujral T.S."/>
<person name="Mulligan L.M."/>
</authorList>
<dbReference type="PubMed" id="20702524"/>
<dbReference type="DOI" id="10.1210/jc.2010-0771"/>
</citation>
<scope>FUNCTION IN CELL ADHESION/MIGRATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="J. Fluoresc." volume="20" first="401" last="405">
<title>Direct visualization of vesicle maturation and plasma membrane protein trafficking.</title>
<authorList>
<person name="Richardson D.S."/>
<person name="Mulligan L.M."/>
</authorList>
<dbReference type="PubMed" id="19823924"/>
<dbReference type="DOI" id="10.1007/s10895-009-0548-x"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Surgery" volume="148" first="1228" last="1236">
<title>A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo.</title>
<authorList>
<person name="Samadi A.K."/>
<person name="Mukerji R."/>
<person name="Shah A."/>
<person name="Timmermann B.N."/>
<person name="Cohen M.S."/>
</authorList>
<dbReference type="PubMed" id="21134556"/>
<dbReference type="DOI" id="10.1016/j.surg.2010.09.026"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="14628" last="14638">
<title>RET modulates cell adhesion via its cleavage by caspase in sympathetic neurons.</title>
<authorList>
<person name="Cabrera J.R."/>
<person name="Bouzas-Rodriguez J."/>
<person name="Tauszig-Delamasure S."/>
<person name="Mehlen P."/>
</authorList>
<dbReference type="PubMed" id="21357690"/>
<dbReference type="DOI" id="10.1074/jbc.M110.195461"/>
</citation>
<scope>FUNCTION IN CELL ADHESION</scope>
<scope>FUNCTION IN APOPTOSIS</scope>
<scope>PROTEOLYTIC PROCESSING BY CASPASE-3 AT ASP-707 AND ASP-1017</scope>
<scope>MUTAGENESIS OF ASP-707; LYS-758 AND 708-ALA--SER-1114</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="17292" last="17302">
<title>Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism.</title>
<authorList>
<person name="Plaza-Menacho I."/>
<person name="Morandi A."/>
<person name="Mologni L."/>
<person name="Boender P."/>
<person name="Gambacorti-Passerini C."/>
<person name="Magee A.I."/>
<person name="Hofstra R.M.W."/>
<person name="Knowles P."/>
<person name="McDonald N.Q."/>
<person name="Isacke C.M."/>
</authorList>
<dbReference type="PubMed" id="21454698"/>
<dbReference type="DOI" id="10.1074/jbc.M110.168500"/>
</citation>
<scope>INTERACTION WITH PTK2/FAK1</scope>
<scope>FUNCTION IN PTK2/FAK1 PHOSPHORYLATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="33577" last="33587">
<title>Structure and chemical inhibition of the RET tyrosine kinase domain.</title>
<authorList>
<person name="Knowles P.P."/>
<person name="Murray-Rust J."/>
<person name="Kjaer S."/>
<person name="Scott R.P."/>
<person name="Hanrahan S."/>
<person name="Santoro M."/>
<person name="Ibanez C.F."/>
<person name="McDonald N.Q."/>
</authorList>
<dbReference type="PubMed" id="16928683"/>
<dbReference type="DOI" id="10.1074/jbc.M605604200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 705-1013 ALONE AND IN COMPLEX WITH INHIBITORS</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>PHOSPHORYLATION AT TYR-900 AND TYR-905</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2010" name="Bioorg. Med. Chem." volume="18" first="1482" last="1496">
<title>Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors.</title>
<authorList>
<person name="Mologni L."/>
<person name="Rostagno R."/>
<person name="Brussolo S."/>
<person name="Knowles P.P."/>
<person name="Kjaer S."/>
<person name="Murray-Rust J."/>
<person name="Rosso E."/>
<person name="Zambon A."/>
<person name="Scapozza L."/>
<person name="McDonald N.Q."/>
<person name="Lucchini V."/>
<person name="Gambacorti-Passerini C."/>
</authorList>
<dbReference type="PubMed" id="20117004"/>
<dbReference type="DOI" id="10.1016/j.bmc.2010.01.011"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 705-1013 IN COMPLEX WITH INHIBITORS</scope>
<scope>ENZYME REGULATION</scope>
<scope>PHOSPHORYLATION AT TYR-905</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Nat. Struct. Mol. Biol." volume="17" first="726" last="731">
<title>Mammal-restricted elements predispose human RET to folding impairment by HSCR mutations.</title>
<authorList>
<person name="Kjaer S."/>
<person name="Hanrahan S."/>
<person name="Totty N."/>
<person name="McDonald N.Q."/>
</authorList>
<dbReference type="PubMed" id="20473317"/>
<dbReference type="DOI" id="10.1038/nsmb.1808"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 29-270</scope>
<scope>GLYCOSYLATION AT ASN-151</scope>
<scope>DISULFIDE BOND</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1997" name="Eur. J. Hum. Genet." volume="5" first="180" last="185">
<title>Mutations in Hirschsprung disease: when does a mutation contribute to the phenotype.</title>
<authorList>
<person name="Hofstra R.M.W."/>
<person name="Osinga J."/>
<person name="Buys C.H.C.M."/>
</authorList>
<dbReference type="PubMed" id="9359036"/>
</citation>
<scope>REVIEW ON HSCR VARIANTS</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1997" name="Hum. Mutat." volume="9" first="97" last="109">
<title>Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease.</title>
<authorList>
<person name="Eng C."/>
<person name="Mulligan L.M."/>
</authorList>
<dbReference type="PubMed" id="9067749"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1997)9:2&lt;97::AID-HUMU1>3.0.CO;2-M"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1993" name="Hum. Mol. Genet." volume="2" first="851" last="856">
<title>Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.</title>
<authorList>
<person name="Donis-Keller H."/>
<person name="Dou S."/>
<person name="Chi D."/>
<person name="Carlson K.M."/>
<person name="Toshima K."/>
<person name="Lairmore T.C."/>
<person name="Howe J.R."/>
<person name="Moley J.F."/>
<person name="Goodfellow P."/>
<person name="Wells S.A. Jr."/>
</authorList>
<dbReference type="PubMed" id="8103403"/>
<dbReference type="DOI" id="10.1093/hmg/2.7.851"/>
</citation>
<scope>VARIANTS MEN2A/MTC TRP-611; SER-618; ARG-620; TYR-620 AND ARG-634</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1993" name="Nature" volume="363" first="458" last="460">
<title>Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.</title>
<authorList>
<person name="Mulligan L.M."/>
<person name="Kwok J.B.J."/>
<person name="Healey C.S."/>
<person name="Elsdon M.J."/>
<person name="Eng C."/>
<person name="Gardner E."/>
<person name="Love D.R."/>
<person name="Mole S.E."/>
<person name="Moore J.K."/>
<person name="Papi L."/>
<person name="Ponder M.A."/>
<person name="Telenius H."/>
<person name="Tunnacliffe A."/>
<person name="Ponder B.A.J."/>
</authorList>
<dbReference type="PubMed" id="8099202"/>
<dbReference type="DOI" id="10.1038/363458a0"/>
</citation>
<scope>VARIANTS MEN2A GLY-618; 632-ASP--ARG-634; GLY-634; PHE-634; TYR-634 AND SER-634</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1994" name="Eur. J. Hum. Genet." volume="2" first="272" last="280">
<title>Heterogeneity and low detection rate of RET mutations in Hirschsprung disease.</title>
<authorList>
<person name="Yin L."/>
<person name="Barone V."/>
<person name="Seri M."/>
<person name="Bolino A."/>
<person name="Bocciardi R."/>
<person name="Ceccherini I."/>
<person name="Pasini B."/>
<person name="Tocco T."/>
<person name="Lerone M."/>
<person name="Cywes S."/>
<person name="Moore S."/>
<person name="Vanderwinden J.-M."/>
<person name="Abramowicz M.J."/>
<person name="Kristoffersson U."/>
<person name="Larsson L.T."/>
<person name="Hamel B.C.J."/>
<person name="Silengo M."/>
<person name="Martucciello G."/>
<person name="Romeo G."/>
</authorList>
<dbReference type="PubMed" id="7704557"/>
</citation>
<scope>VARIANTS HSCR1 PRO-40; LEU-399; GLN-762; PRO-765; GLN-897; GLY-972 AND LEU-973</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="237" last="241">
<title>Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.</title>
<authorList>
<person name="Eng C."/>
<person name="Smith D.P."/>
<person name="Mulligan L.M."/>
<person name="Nagai M.A."/>
<person name="Healey C.S."/>
<person name="Ponder M.A."/>
<person name="Gardner E."/>
<person name="Scheumann G.F."/>
<person name="Jackson C.E."/>
<person name="Tunnacliffe A."/>
<person name="Ponder B.A.J."/>
</authorList>
<dbReference type="PubMed" id="7911697"/>
<dbReference type="DOI" id="10.1093/hmg/3.2.237"/>
</citation>
<scope>VARIANT MEN2B THR-918</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="635" last="638">
<title>Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests.</title>
<authorList>
<person name="Xue F."/>
<person name="Yu H."/>
<person name="Maurer L.H."/>
<person name="Memoli V.A."/>
<person name="Nutile-Mcmenemy N."/>
<person name="Schuster M.K."/>
<person name="Browden D.W."/>
<person name="Mao J.-I."/>
<person name="Noll W.W."/>
</authorList>
<dbReference type="PubMed" id="7915165"/>
<dbReference type="DOI" id="10.1093/hmg/3.4.635"/>
</citation>
<scope>VARIANTS MEN2A/MTC ARG-618; SER-618; PHE-620; ARG-620; PHE-634; GLY-634 AND TYR-634</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="1895" last="1897">
<title>RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer.</title>
<authorList>
<person name="Blaugrund J.E."/>
<person name="Johns M.M. Jr."/>
<person name="Eby Y.J."/>
<person name="Ball D.W."/>
<person name="Baylin S.B."/>
<person name="Hruban R.H."/>
<person name="Sidransky D."/>
</authorList>
<dbReference type="PubMed" id="7849720"/>
<dbReference type="DOI" id="10.1093/hmg/3.10.1895"/>
</citation>
<scope>VARIANTS MTC/MEN2A TYR-609; ARG-618; SER-618 AND SER-620</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="1939" last="1943">
<title>RET proto-oncogene mutations in French MEN 2A and FMTC families.</title>
<authorList>
<person name="Schuffenecker I."/>
<person name="Billaud M."/>
<person name="Calender A."/>
<person name="Chambe B."/>
<person name="Ginet N."/>
<person name="Calmettes C."/>
<person name="Modigliani E."/>
<person name="Lenoir G.M."/>
</authorList>
<dbReference type="PubMed" id="7874109"/>
<dbReference type="DOI" id="10.1093/hmg/3.11.1939"/>
</citation>
<scope>VARIANTS MTC</scope>
<scope>VARIANTS MEN2A</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="2163" last="2167">
<title>Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene.</title>
<authorList>
<person name="Mulligan L.M."/>
<person name="Eng C."/>
<person name="Attie T."/>
<person name="Lyonnet S."/>
<person name="Marsh D.J."/>
<person name="Hyland V.J."/>
<person name="Robinson B.G."/>
<person name="Frilling A."/>
<person name="Verellen-Dumoulin C."/>
<person name="Safar A."/>
<person name="Venter D.J."/>
<person name="Munnich A."/>
<person name="Ponder B.A.J."/>
</authorList>
<dbReference type="PubMed" id="7881414"/>
<dbReference type="DOI" id="10.1093/hmg/3.12.2163"/>
</citation>
<scope>VARIANTS HSCR1 TRP-609; ARG-618 AND ARG-620</scope>
<scope>VARIANT MEN2A ARG-618</scope>
<scope>VARIANT MTC ARG-620</scope>
</reference>
<reference key="45">
<citation type="journal article" date="1994" name="Nature" volume="367" first="375" last="376">
<title>A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.</title>
<authorList>
<person name="Hofstra R.M.W."/>
<person name="Landsvater R.M."/>
<person name="Ceccherini I."/>
<person name="Stulp R.P."/>
<person name="Stelwagen T."/>
<person name="Luo Y."/>
<person name="Pasini B."/>
<person name="Hoeppener J.W.M."/>
<person name="Ploos van Amstel H.K."/>
<person name="Romeo G."/>
<person name="Lips C.J.M."/>
<person name="Buys C.H.C.M."/>
</authorList>
<dbReference type="PubMed" id="7906866"/>
<dbReference type="DOI" id="10.1038/367375a0"/>
</citation>
<scope>VARIANT MEN2B THR-918</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1994" name="Nature" volume="367" first="377" last="378">
<title>Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease.</title>
<authorList>
<person name="Romeo G."/>
<person name="Ronchetto P."/>
<person name="Luo Y."/>
<person name="Barone V."/>
<person name="Seri M."/>
<person name="Ceccherini I."/>
<person name="Pasini B."/>
<person name="Bocciardi R."/>
<person name="Lerone M."/>
<person name="Kaarlainen H."/>
<person name="Martucciello G."/>
</authorList>
<dbReference type="PubMed" id="8114938"/>
<dbReference type="DOI" id="10.1038/367377a0"/>
</citation>
<scope>VARIANTS HSCR1 PRO-765; GLN-897 AND GLY-972</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1994" name="Nature" volume="367" first="378" last="380">
<title>Mutations of the RET proto-oncogene in Hirschsprung's disease.</title>
<authorList>
<person name="Edery P."/>
<person name="Lyonnet S."/>
<person name="Mulligan L.M."/>
<person name="Pelet A."/>
<person name="Dow E."/>
<person name="Abel L."/>
<person name="Holder S."/>
<person name="Nihoul-Fkete C."/>
<person name="Ponder B.A.J."/>
<person name="Munnich A."/>
</authorList>
<dbReference type="PubMed" id="8114939"/>
<dbReference type="DOI" id="10.1038/367378a0"/>
</citation>
<scope>VARIANTS HSCR1 LEU-32; LEU-64; GLN-330 AND LEU-393</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="1579" last="1583">
<title>Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.</title>
<authorList>
<person name="Carlson K.M."/>
<person name="Dou S."/>
<person name="Chi D."/>
<person name="Scavarda N."/>
<person name="Toshima K."/>
<person name="Jackson C.E."/>
<person name="Wells S.A. Jr."/>
<person name="Goodfellow P.J."/>
<person name="Donis-Keller H."/>
</authorList>
<dbReference type="PubMed" id="7906417"/>
<dbReference type="DOI" id="10.1073/pnas.91.4.1579"/>
</citation>
<scope>VARIANT MEN2B THR-918</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1995" name="Cancer" volume="76" first="479" last="489">
<title>Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas.</title>
<authorList>
<person name="Komminoth P."/>
<person name="Kunz E.K."/>
<person name="Matias-Guiu X."/>
<person name="Hiort O."/>
<person name="Christiansen G."/>
<person name="Colomer A."/>
<person name="Roth J."/>
<person name="Heitz P.U."/>
</authorList>
<dbReference type="PubMed" id="8625130"/>
<dbReference type="DOI" id="10.1002/1097-0142(19950801)76:3&lt;479::AID-CNCR2820760319>3.0.CO;2-M"/>
</citation>
<scope>VARIANTS MTC; MEN2A AND MEN2B</scope>
</reference>
<reference key="50">
<citation type="journal article" date="1995" name="Hum. Genet." volume="95" first="187" last="190">
<title>Germline mutations of the RET proto-oncogene in eight Japanese patients with multiple endocrine neoplasia type 2A (MEN2A).</title>
<authorList>
<person name="Takiguchi-Shirahama S."/>
<person name="Koyama K."/>
<person name="Miyauchi A."/>
<person name="Wakasugi T."/>
<person name="Oishi S."/>
<person name="Takami H."/>
<person name="Hikiji K."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="7860065"/>
<dbReference type="DOI" id="10.1007/BF00209399"/>
</citation>
<scope>VARIANTS MEN2A SER-618; SER-620; ARG-634 AND TYR-634</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="821" last="830">
<title>Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease.</title>
<authorList>
<person name="Angrist M."/>
<person name="Bolk S."/>
<person name="Thiel B."/>
<person name="Puffenberger E.G."/>
<person name="Hofstra R.M.W."/>
<person name="Buys C.H.C.M."/>
<person name="Cass D.T."/>
<person name="Chakravarti A."/>
</authorList>
<dbReference type="PubMed" id="7633441"/>
<dbReference type="DOI" id="10.1093/hmg/4.5.821"/>
</citation>
<scope>VARIANTS HSCR1 LEU-20; SER-93; GLN-330; TYR-609 AND ARG-620</scope>
<scope>VARIANT CYS-982</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="52">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="1381" last="1386">
<title>Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.</title>
<authorList>
<person name="Attie T."/>
<person name="Pelet A."/>
<person name="Edery P."/>
<person name="Eng C."/>
<person name="Mulligan L.M."/>
<person name="Amiel J."/>
<person name="Boutrand L."/>
<person name="Beldjord C."/>
<person name="Nihoul-Fekete C."/>
<person name="Munnich A."/>
<person name="Ponder B.A.J."/>
<person name="Lyonnet S."/>
</authorList>
<dbReference type="PubMed" id="7581377"/>
<dbReference type="DOI" id="10.1093/hmg/4.8.1381"/>
</citation>
<scope>VARIANTS HSCR1</scope>
<source>
<tissue>Leukocyte</tissue>
</source>
</reference>
<reference key="53">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="1987" last="1988">
<title>Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B.</title>
<authorList>
<person name="Kitamura Y."/>
<person name="Scavarda N."/>
<person name="Wells S.A. Jr."/>
<person name="Jackson C.E."/>
<person name="Goodfellow P.J."/>
</authorList>
<dbReference type="PubMed" id="8595427"/>
<dbReference type="DOI" id="10.1093/hmg/4.10.1987"/>
</citation>
<scope>VARIANT MEN2B THR-918</scope>
<scope>VARIANT TYR-922</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1995" name="Oncogene" volume="10" first="509" last="513">
<title>A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.</title>
<authorList>
<person name="Eng C."/>
<person name="Smith D.P."/>
<person name="Mulligan L.M."/>
<person name="Healey C.S."/>
<person name="Zvelebil M.J."/>
<person name="Stonehouse T.J."/>
<person name="Ponder M.A."/>
<person name="Jackson C.E."/>
<person name="Waterfield M.D."/>
<person name="Ponder B.A.J."/>
</authorList>
<dbReference type="PubMed" id="7845675"/>
</citation>
<scope>VARIANT MTC ASP-768</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1995" name="Oncogene" volume="10" first="2415" last="2419">
<title>RET mutations in exons 13 and 14 of FMTC patients.</title>
<authorList>
<person name="Bolino A."/>
<person name="Schuffenecker I."/>
<person name="Luo Y."/>
<person name="Seri M."/>
<person name="Silengo M."/>
<person name="Tocco T."/>
<person name="Chabrier G."/>
<person name="Houdent C."/>
<person name="Murat A."/>
<person name="Schlumberger M."/>
<person name="Tournaire J."/>
<person name="Lenoir G.M."/>
<person name="Romeo G."/>
</authorList>
<dbReference type="PubMed" id="7784092"/>
</citation>
<scope>VARIANTS MTC ASP-768 AND LEU-804</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1996" name="Am. J. Hum. Genet." volume="59" first="A263" last="A263">
<title>Mutations in three genes are found associated with the development of Hirschsprung disease: RET, EDNRB and EDN3.</title>
<authorList>
<person name="Hofstra R.M.W."/>
<person name="Osinga J."/>
<person name="Stulp R.P."/>
<person name="Scheffer H."/>
<person name="Meijers C."/>
<person name="Buys C.H.C.M."/>
</authorList>
</citation>
<scope>VARIANTS HSCR1 TYR-157; LYS-359; TYR-609; ARG-620; ASN-1059 DEL AND PRO-1061</scope>
</reference>
<reference key="57">
<citation type="journal article" date="1996" name="Eur. J. Hum. Genet." volume="4" first="356" last="358">
<title>Prevalence and parental origin of de novo RET mutations in Hirschsprung's disease.</title>
<authorList>
<person name="Yin L."/>
<person name="Seri M."/>
<person name="Barone V."/>
<person name="Tocco T."/>
<person name="Scaranari M."/>
<person name="Romeo G."/>
</authorList>
<dbReference type="PubMed" id="9043870"/>
</citation>
<scope>VARIANTS HSCR1 PRO-40 AND PRO-765</scope>
</reference>
<reference key="58">
<citation type="journal article" date="1996" name="Hum. Genet." volume="97" first="11" last="14">
<title>Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A.</title>
<authorList>
<person name="Landsvater R.M."/>
<person name="Jansen R.P.M."/>
<person name="Hofstra R.M.W."/>
<person name="Buys C.H.C.M."/>
<person name="Lips C.J.M."/>
<person name="van Amstel H.K.P."/>
</authorList>
<dbReference type="PubMed" id="8557249"/>
<dbReference type="DOI" id="10.1007/BF00218825"/>
</citation>
<scope>VARIANTS MTC/MEN2A</scope>
</reference>
<reference key="59">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="8" first="64" last="70">
<title>Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.</title>
<authorList>
<person name="Kambouris M."/>
<person name="Jackson C.E."/>
<person name="Feldman G.L."/>
</authorList>
<dbReference type="PubMed" id="8807338"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)8:1&lt;64::AID-HUMU9>3.3.CO;2-N"/>
</citation>
<scope>VARIANTS MEN2A</scope>
<scope>VARIANT MTC ASP-768</scope>
<scope>VARIANT MEN2B THR-918</scope>
</reference>
<reference key="60">
<citation type="journal article" date="1996" name="J. Clin. Endocrinol. Metab." volume="81" first="1780" last="1783">
<title>Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype.</title>
<authorList>
<person name="Frank-Raue K."/>
<person name="Hoeppner W."/>
<person name="Frilling A."/>
<person name="Kotzerke J."/>
<person name="Dralle H."/>
<person name="Haase R."/>
<person name="Mann K."/>
<person name="Seif F."/>
<person name="Kirchner R."/>
<person name="Rendl J."/>
<person name="Deckart H.F."/>
<person name="Ritter M.M."/>
<person name="Hampel R."/>
<person name="Klempa J."/>
<person name="Scholz G.H."/>
<person name="Raue F."/>
<person name="Bogner U."/>
<person name="Brabant G."/>
<person name="Grussendorf M."/>
<person name="Hartenstein C.H."/>
<person name="Heidemann P."/>
<person name="Hensen J."/>
<person name="Doerr A.G."/>
<person name="Hoehne T."/>
<person name="Hoernig-Franz I."/>
<person name="Huefner M."/>
<person name="Kress J."/>
<person name="Langer H.J."/>
<person name="Lottermoser K."/>
<person name="Schweikert H.U."/>
<person name="Kusterer K."/>
<person name="Menken U."/>
<person name="Mercier J."/>
<person name="Oelkers W."/>
<person name="Sauer J."/>
<person name="Simon D."/>
<person name="Starrach G."/>
<person name="Ziegler R."/>
</authorList>
<dbReference type="PubMed" id="8626834"/>
<dbReference type="DOI" id="10.1210/jcem.81.5.8626834"/>
</citation>
<scope>VARIANTS MEN2A</scope>
</reference>
<reference key="61">
<citation type="journal article" date="1997" name="Hum. Mol. Genet." volume="6" first="587" last="590">
<title>A duplication of 12 bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A.</title>
<authorList>
<person name="Hoeppner W."/>
<person name="Ritter M.M."/>
</authorList>
<dbReference type="PubMed" id="9097963"/>
<dbReference type="DOI" id="10.1093/hmg/6.4.587"/>
</citation>
<scope>VARIANT MEN2A HIS-GLU-LEU-CYS-634 INS</scope>
</reference>
<reference key="62">
<citation type="journal article" date="1997" name="Hum. Mutat." volume="9" first="243" last="249">
<title>Frequency of RET mutations in long- and short-segment Hirschsprung disease.</title>
<authorList>
<person name="Seri M."/>
<person name="Yin L."/>
<person name="Barone V."/>
<person name="Bolino A."/>
<person name="Celli I."/>
<person name="Bocciardi R."/>
<person name="Pasini B."/>
<person name="Ceccherini I."/>
<person name="Lerone M."/>
<person name="Kristoffersson U."/>
<person name="Larsson L.T."/>
<person name="Casasa J.M."/>
<person name="Cass D.T."/>
<person name="Abramowicz M.J."/>
<person name="Vanderwinden J.-M."/>
<person name="Kravcenkiene I."/>
<person name="Baric I."/>
<person name="Silengo M."/>
<person name="Martucciello G."/>
<person name="Romeo G."/>
</authorList>
<dbReference type="PubMed" id="9090527"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1997)9:3&lt;243::AID-HUMU5>3.3.CO;2-N"/>
</citation>
<scope>VARIANTS HSCR1 PRO-180; GLN-313; ARG-620 AND PHE-791</scope>
</reference>
<reference key="63">
<citation type="journal article" date="1997" name="Hum. Mutat." volume="10" first="155" last="159">
<title>Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting.</title>
<authorList>
<person name="Peretz H."/>
<person name="Luboshitsky R."/>
<person name="Baron E."/>
<person name="Biton A."/>
<person name="Gershoni R."/>
<person name="Usher S."/>
<person name="Grynberg E."/>
<person name="Yakobson E."/>
<person name="Graff E."/>
<person name="Lapidot M."/>
</authorList>
<dbReference type="PubMed" id="9259198"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1997)10:2&lt;155::AID-HUMU7>3.3.CO;2-G"/>
</citation>
<scope>VARIANT MTC ARG-618</scope>
<scope>VARIANT HSCR1 ARG-618</scope>
</reference>
<reference key="64">
<citation type="journal article" date="1997" name="J. Clin. Endocrinol. Metab." volume="82" first="3902" last="3904">
<title>Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation.</title>
<authorList>
<person name="Gimm O."/>
<person name="Marsh D.J."/>
<person name="Andrew S.D."/>
<person name="Frilling A."/>
<person name="Dahia P.L.M."/>
<person name="Mulligan L.M."/>
<person name="Zajac J.D."/>
<person name="Robinson B.G."/>
<person name="Eng C."/>
</authorList>
<dbReference type="PubMed" id="9360560"/>
<dbReference type="DOI" id="10.1210/jcem.82.11.4508"/>
</citation>
<scope>VARIANT MEN2B PHE-883</scope>
<source>
<tissue>Peripheral blood leukocyte</tissue>
</source>
</reference>
<reference key="65">
<citation type="journal article" date="1997" name="J. Clin. Endocrinol. Metab." volume="82" first="4176" last="4178">
<title>A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma.</title>
<authorList>
<person name="Hofstra R.M.W."/>
<person name="Fattoruso O."/>
<person name="Quadro L."/>
<person name="Wu Y."/>
<person name="Libroia A."/>
<person name="Verga U."/>
<person name="Colantuoni V."/>
<person name="Buys C.H.C.M."/>
</authorList>
<dbReference type="PubMed" id="9398735"/>
<dbReference type="DOI" id="10.1210/jcem.82.12.4439"/>
</citation>
<scope>VARIANT MTC ALA-891</scope>
</reference>
<reference key="66">
<citation type="journal article" date="1997" name="J. Pediatr. Surg." volume="32" first="501" last="504">
<title>Mutation analysis of the RET, the endothelin-B receptor, and the endothelin-3 genes in sporadic cases of Hirschsprung's disease.</title>
<authorList>
<person name="Kusafuka T."/>
<person name="Wang Y."/>
<person name="Puri P."/>
</authorList>
<dbReference type="PubMed" id="9094028"/>
<dbReference type="DOI" id="10.1016/S0022-3468(97)90616-3"/>
</citation>
<scope>VARIANTS HSCR1 SER-174 AND TYR-197</scope>
</reference>
<reference key="67">
<citation type="journal article" date="1997" name="Oncogene" volume="14" first="3103" last="3106">
<title>Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC.</title>
<authorList>
<person name="Kitamura Y."/>
<person name="Goodfellow P.J."/>
<person name="Shimizu K."/>
<person name="Nagahama M."/>
<person name="Ito K."/>
<person name="Kitagawa W."/>
<person name="Akasu H."/>
<person name="Takami H."/>
<person name="Tanaka S."/>
<person name="Wells S.A. Jr."/>
</authorList>
<dbReference type="PubMed" id="9223675"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201102"/>
</citation>
<scope>VARIANTS MTC; MEN2A AND MEN2B</scope>
<scope>VARIANT SER-691</scope>
</reference>
<reference key="68">
<citation type="journal article" date="1997" name="Oncogene" volume="15" first="1213" last="1217">
<title>Germline mutation of RET codon 883 in two cases of de novo MEN 2B.</title>
<authorList>
<person name="Smith D.P."/>
<person name="Houghton C."/>
<person name="Ponder B.A.J."/>
</authorList>
<dbReference type="PubMed" id="9294615"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201481"/>
</citation>
<scope>VARIANT MEN2B PHE-883</scope>
</reference>
<reference key="69">
<citation type="journal article" date="1998" name="Am. J. Hum. Genet." volume="62" first="715" last="717">
<title>Mutations of the RET-GDNF signaling pathway in Ondine's curse.</title>
<authorList>
<person name="Amiel J."/>
<person name="Salomon R."/>
<person name="Attie T."/>
<person name="Pelet A."/>
<person name="Trang H."/>
<person name="Mokhtari M."/>
<person name="Gaultier C."/>
<person name="Munnich A."/>
<person name="Lyonnet S."/>
</authorList>
<dbReference type="PubMed" id="9497256"/>
<dbReference type="DOI" id="10.1086/301759"/>
</citation>
<scope>VARIANT CCHS LEU-1039</scope>
<scope>VARIANT SER-691</scope>
</reference>
<reference key="70">
<citation type="journal article" date="1998" name="Am. J. Med. Genet." volume="78" first="271" last="273">
<title>Novel point mutation in exon 10 of the RET proto-oncogene in a family with medullary thyroid carcinoma.</title>
<authorList>
<person name="Oriola J."/>
<person name="Paramo C."/>
<person name="Halperin I."/>
<person name="Garcia-Mayor R.V."/>
<person name="Rivera-Fillat F."/>
</authorList>
<dbReference type="PubMed" id="9677065"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19980707)78:3&lt;271::AID-AJMG13>3.0.CO;2-C"/>
</citation>
<scope>VARIANT MTC GLY-611</scope>
</reference>
<reference key="71">
<citation type="journal article" date="1998" name="Hum. Genet." volume="103" first="145" last="148">
<title>Phenotypic variation in a family with mutations in two Hirschsprung-related genes (RET and endothelin receptor B).</title>
<authorList>
<person name="Svensson P.J."/>
<person name="Anvret M."/>
<person name="Molander M.L."/>
<person name="Nordenskjold A."/>
</authorList>
<dbReference type="PubMed" id="9760196"/>
<dbReference type="DOI" id="10.1007/s004390050797"/>
</citation>
<scope>VARIANT CYS-982</scope>
</reference>
<reference key="72">
<citation type="journal article" date="1998" name="Hum. Mol. Genet." volume="7" first="129" last="134">
<title>Hirschsprung disease in MEN 2A: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation.</title>
<authorList>
<person name="Decker R.A."/>
<person name="Peacock M.L."/>
<person name="Watson P."/>
</authorList>
<dbReference type="PubMed" id="9384613"/>
<dbReference type="DOI" id="10.1093/hmg/7.1.129"/>
</citation>
<scope>VARIANTS MEN2A TYR-609; SER-618; ARG-620 AND TRP-620</scope>
<scope>VARIANTS HSCR1 TYR-609; SER-618; ARG-620 AND TRP-620</scope>
</reference>
<reference key="73">
<citation type="journal article" date="1998" name="Hum. Mutat. Suppl." volume="1" first="S128" last="S130">
<title>Duplication of 9 base pairs in the critical cysteine-rich domain of the RET proto-oncogene causes multiple endocrine neoplasia type 2A.</title>
<authorList>
<person name="Hoeppner W."/>
<person name="Dralle H."/>
<person name="Brabant G."/>
</authorList>
<dbReference type="PubMed" id="9452064"/>
</citation>
<scope>VARIANT MEN2A CYS-ARG-THR-636 INS</scope>
</reference>
<reference key="74">
<citation type="journal article" date="1998" name="Hum. Mutat. Suppl." volume="1" first="S167" last="S171">
<title>A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma.</title>
<authorList>
<person name="Fattoruso O."/>
<person name="Quadro L."/>
<person name="Libroia A."/>
<person name="Verga U."/>
<person name="Lupoli G."/>
<person name="Cascone E."/>
<person name="Colantuoni V."/>
</authorList>
<dbReference type="PubMed" id="9452077"/>
</citation>
<scope>VARIANT MTC MET-804</scope>
</reference>
<reference key="75">
<citation type="journal article" date="1998" name="J. Clin. Endocrinol. Metab." volume="83" first="770" last="774">
<title>A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.</title>
<authorList>
<person name="Berndt I."/>
<person name="Reuter M."/>
<person name="Saller B."/>
<person name="Frank-Raue K."/>
<person name="Groth P."/>
<person name="Grussendorf M."/>
<person name="Raue F."/>
<person name="Ritter M.M."/>
<person name="Hoeppner W."/>
</authorList>
<dbReference type="PubMed" id="9506724"/>
<dbReference type="DOI" id="10.1210/jcem.83.3.4619"/>
</citation>
<scope>VARIANTS MTC/MEN2A PHE-790 AND PHE-791</scope>
</reference>
<reference key="76">
<citation type="journal article" date="1998" name="J. Hum. Genet." volume="43" first="101" last="106">
<title>Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma.</title>
<authorList>
<person name="Shirahama S."/>
<person name="Ogura K."/>
<person name="Takami H."/>
<person name="Ito K."/>
<person name="Tohsen T."/>
<person name="Miyauchi A."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="9621513"/>
<dbReference type="DOI" id="10.1007/s100380050048"/>
</citation>
<scope>VARIANTS MTC AND MEN2A</scope>
</reference>
<reference key="77">
<citation type="journal article" date="1999" name="Am. J. Hum. Genet." volume="64" first="1216" last="1221">
<title>Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease.</title>
<authorList>
<person name="Auricchio A."/>
<person name="Griseri P."/>
<person name="Carpentieri M.L."/>
<person name="Betsos N."/>
<person name="Staiano A."/>
<person name="Tozzi A."/>
<person name="Priolo M."/>
<person name="Thompson H."/>
<person name="Bocciardi R."/>
<person name="Romeo G."/>
<person name="Ballabio A."/>
<person name="Ceccherini I."/>
</authorList>
<dbReference type="PubMed" id="10090908"/>
<dbReference type="DOI" id="10.1086/302329"/>
</citation>
<scope>VARIANTS HSCR1 LYS-626 AND GLN-813</scope>
</reference>
<reference key="78">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="1989" last="1999">
<title>Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.</title>
<authorList>
<person name="Geneste O."/>
<person name="Bidaud C."/>
<person name="De Vita G."/>
<person name="Hofstra R.M.W."/>
<person name="Tartare-Deckert S."/>
<person name="Buys C.H.C.M."/>
<person name="Lenoir G.M."/>
<person name="Santoro M."/>
<person name="Billaud M."/>
</authorList>
<dbReference type="PubMed" id="10484767"/>
<dbReference type="DOI" id="10.1093/hmg/8.11.1989"/>
</citation>
<scope>VARIANTS HSCR1 ASN-1059 DEL AND PRO-1061</scope>
</reference>
<reference key="79">
<citation type="journal article" date="1999" name="J. Clin. Endocrinol. Metab." volume="84" first="1700" last="1704">
<title>A novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma.</title>
<authorList>
<person name="Pigny P."/>
<person name="Bauters C."/>
<person name="Wemeau J.-L."/>
<person name="Houcke M.L."/>
<person name="Crepin M."/>
<person name="Caron P."/>
<person name="Giraud S."/>
<person name="Calender A."/>
<person name="Buisine M.-P."/>
<person name="Kerckaert J.-P."/>
<person name="Porchet N."/>
</authorList>
<dbReference type="PubMed" id="10323403"/>
<dbReference type="DOI" id="10.1210/jcem.84.5.5665"/>
</citation>
<scope>VARIANT MTC GLU-GLU-CYS-531 INS</scope>
</reference>
<reference key="80">
<citation type="journal article" date="1999" name="J. Clin. Endocrinol. Metab." volume="84" first="3522" last="3527">
<title>A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene.</title>
<authorList>
<person name="Tessitore A."/>
<person name="Sinisi A.A."/>
<person name="Pasquali D."/>
<person name="Cardone M."/>
<person name="Vitale D."/>
<person name="Bellastella A."/>
<person name="Colantuoni V."/>
</authorList>
<dbReference type="PubMed" id="10522989"/>
<dbReference type="DOI" id="10.1210/jcem.84.10.6056"/>
</citation>
<scope>VARIANT MEN2A GLY-640</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2000" name="Exp. Clin. Endocrinol. Diabetes" volume="108" first="128" last="132">
<title>A RET double mutation in the germline of a kindred with FMTC.</title>
<authorList>
<person name="Bartsch D.K."/>
<person name="Hasse C."/>
<person name="Schug C."/>
<person name="Barth P."/>
<person name="Rothmund M."/>
<person name="Hoeppner W."/>
</authorList>
<dbReference type="PubMed" id="10826520"/>
<dbReference type="DOI" id="10.1055/s-2000-5806"/>
</citation>
<scope>VARIANTS MTC MET-804 AND LEU-844</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2000" name="Hum. Mutat." volume="15" first="122" last="122">
<title>A new germline mutation, R600Q, within the coding region of RET proto-oncogene: a rare polymorphism or a MEN 2 causing mutation?</title>
<authorList>
<person name="Saez M.E."/>
<person name="Ruiz A."/>
<person name="Cebrian A."/>
<person name="Morales F."/>
<person name="Robledo M."/>
<person name="Antinolo G."/>
<person name="Borrego S."/>
</authorList>
<dbReference type="PubMed" id="10612852"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(200001)15:1&lt;122::AID-HUMU41>3.0.CO;2-7"/>
</citation>
<scope>VARIANT GLN-600</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="268" last="273">
<title>A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus.</title>
<authorList>
<person name="Bolk S."/>
<person name="Pelet A."/>
<person name="Hofstra R.M.W."/>
<person name="Angrist M."/>
<person name="Salomon R."/>
<person name="Croaker D."/>
<person name="Buys C.H.C.M."/>
<person name="Lyonnet S."/>
<person name="Chakravarti A."/>
</authorList>
<dbReference type="PubMed" id="10618407"/>
<dbReference type="DOI" id="10.1073/pnas.97.1.268"/>
</citation>
<scope>VARIANTS HSCR1 LEU-32; CYS-77; TRP-360 AND LYS-394</scope>
</reference>
<reference key="84">
<citation type="journal article" date="2001" name="J. Mol. Med." volume="79" first="609" last="612">
<title>Three novel mutations in the RET proto-oncogene.</title>
<authorList>
<person name="Kalinin V.N."/>
<person name="Amosenko F.A."/>
<person name="Shabanov M.A."/>
<person name="Lubchenko L.N."/>
<person name="Hosch S.B."/>
<person name="Garkavtseva R.F."/>
<person name="Izbicki J.R."/>
</authorList>
<dbReference type="PubMed" id="11692159"/>
<dbReference type="DOI" id="10.1007/s001090100250"/>
</citation>
<scope>VARIANTS MTC GLY-639; GLY-641 AND PHE-922</scope>
</reference>
<reference key="85">
<citation type="journal article" date="2002" name="N. Engl. J. Med." volume="346" first="1459" last="1466">
<title>Germ-line mutations in nonsyndromic pheochromocytoma.</title>
<authorList>
<consortium name="The Freiburg-Warsaw-Columbus pheochromocytoma study group"/>
<person name="Neumann H.P.H."/>
<person name="Bausch B."/>
<person name="McWhinney S.R."/>
<person name="Bender B.U."/>
<person name="Gimm O."/>
<person name="Franke G."/>
<person name="Schipper J."/>
<person name="Klisch J."/>
<person name="Altehoefer C."/>
<person name="Zerres K."/>
<person name="Januszewicz A."/>
<person name="Smith W.M."/>
<person name="Munk R."/>
<person name="Manz T."/>
<person name="Glaesker S."/>
<person name="Apel T.W."/>
<person name="Treier M."/>
<person name="Reineke M."/>
<person name="Walz M.K."/>
<person name="Hoang-Vu C."/>
<person name="Brauckhoff M."/>
<person name="Klein-Franke A."/>
<person name="Klose P."/>
<person name="Schmidt H."/>
<person name="Maier-Woelfle M."/>
<person name="Peczkowska M."/>
<person name="Szmigielski C."/>
<person name="Eng C."/>
</authorList>
<dbReference type="PubMed" id="12000816"/>
<dbReference type="DOI" id="10.1056/NEJMoa020152"/>
</citation>
<scope>VARIANTS PHEOCHROMOCYTOMA ARG-634; GLY-634; TYR-634; SER-634; PHE-634; TRP-634 AND PHE-791</scope>
</reference>
<reference key="86">
<citation type="journal article" date="2002" name="Tohoku J. Exp. Med." volume="196" first="241" last="246">
<title>Congenital central hypoventilation syndrome: a novel mutation of the RET gene in an isolated case.</title>
<authorList>
<person name="Kanai M."/>
<person name="Numakura C."/>
<person name="Sasaki A."/>
<person name="Shirahata E."/>
<person name="Akaba K."/>
<person name="Hashimoto M."/>
<person name="Hasegawa H."/>
<person name="Shirasawa S."/>
<person name="Hayasaka K."/>
</authorList>
<dbReference type="PubMed" id="12086152"/>
<dbReference type="DOI" id="10.1620/tjem.196.241"/>
</citation>
<scope>VARIANT CCHS HIS-114</scope>
</reference>
<reference key="87">
<citation type="journal article" date="2003" name="Hum. Genet." volume="114" first="22" last="26">
<title>Molecular analysis of congenital central hypoventilation syndrome.</title>
<authorList>
<person name="Sasaki A."/>
<person name="Kanai M."/>
<person name="Kijima K."/>
<person name="Akaba K."/>
<person name="Hashimoto M."/>
<person name="Hasegawa H."/>
<person name="Otaki S."/>
<person name="Koizumi T."/>
<person name="Kusuda S."/>
<person name="Ogawa Y."/>
<person name="Tuchiya K."/>
<person name="Yamamoto W."/>
<person name="Nakamura T."/>
<person name="Hayasaka K."/>
</authorList>
<dbReference type="PubMed" id="14566559"/>
<dbReference type="DOI" id="10.1007/s00439-003-1036-z"/>
</citation>
<scope>VARIANTS ASN-489; SER-691 AND CYS-982</scope>
<scope>VARIANTS CCHS HIS-67; HIS-114 AND GLU-432</scope>
</reference>
<reference key="88">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] GLY-145; TRP-360 AND GLU-593</scope>
</reference>
<reference key="89">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] GLN-163; ASN-278; MET-292; ASN-489; SER-691; THR-749; SER-826; LEU-844; CYS-982 AND TYR-1112</scope>
</reference>
<reference key="90">
<citation type="journal article" date="2008" name="Am. J. Hum. Genet." volume="82" first="344" last="351">
<title>Renal aplasia in humans is associated with RET mutations.</title>
<authorList>
<person name="Skinner M.A."/>
<person name="Safford S.D."/>
<person name="Reeves J.G."/>
<person name="Jackson M.E."/>
<person name="Freemerman A.J."/>
</authorList>
<dbReference type="PubMed" id="18252215"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2007.10.008"/>
</citation>
<scope>VARIANTS THR-198; ALA-376; HIS-394; ILE-778; SER-894; THR-918; LEU-1049 AND SER-1067</scope>
<scope>POSSIBLE INVOLVEMENT IN RENAL AGENESIS</scope>
<scope>CHARACTERIZATION OF VARIANTS THR-198; ALA-376; HIS-394; ILE-778; SER-894; LEU-1049 AND SER-1067</scope>
</reference>
<reference key="91">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E28986" last="E28986">
<title>RET mutational spectrum in Hirschsprung disease: evaluation of 601 Chinese patients.</title>
<authorList>
<person name="So M.T."/>
<person name="Leon T.Y."/>
<person name="Cheng G."/>
<person name="Tang C.S."/>
<person name="Miao X.P."/>
<person name="Cornes B.K."/>
<person name="Diem N.N."/>
<person name="Cui L."/>
<person name="Ngan E.S."/>
<person name="Lui V.C."/>
<person name="Wu X.Z."/>
<person name="Wang B."/>
<person name="Wang H."/>
<person name="Yuan Z.W."/>
<person name="Huang L.M."/>
<person name="Li L."/>
<person name="Xia H."/>
<person name="Zhu D."/>
<person name="Liu J."/>
<person name="Nguyen T.L."/>
<person name="Chan I.H."/>
<person name="Chung P.H."/>
<person name="Liu X.L."/>
<person name="Zhang R."/>
<person name="Wong K.K."/>
<person name="Sham P.C."/>
<person name="Cherny S.S."/>
<person name="Tam P.K."/>
<person name="Garcia-Barcelo M.M."/>
</authorList>
<dbReference type="PubMed" id="22174939"/>
<dbReference type="DOI" id="10.1371/journal.pone.0028986"/>
</citation>
<scope>VARIANTS HSCR1 549-LYS-GLY-550 DEL; CYS-114; HIS-114; GLY-145; LEU-155; PRO-175; ALA-278; PRO-278; ASN-300; GLN-313; ILE-316; LEU-339; TYR-353; GLN-360; MET-397; MET-412; ARG-423; LYS-480; GLN-595; LEU-679; GLN-694; SER-783; ARG-830; THR-907; LEU-961; VAL-1052; CYS-1062 AND THR-1064</scope>
<scope>VARIANTS ASN-278 AND MET-292</scope>
</reference>
<comment type="function">
<text evidence="40 45 46 48 49">Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands. Phosphorylates PTK2/FAK1. Regulates both cell death/survival balance and positional information. Required for the molecular mechanisms orchestration during intestine organogenesis; involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue. Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner. Involved in the development of the neural crest. Active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage. Acts as a dependence receptor; in the presence of the ligand GDNF in somatotrophs (within pituitary), promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF. Regulates nociceptor survival and size. Triggers the differentiation of rapidly adapting (RA) mechanoreceptors. Mediator of several diseases such as neuroendocrine cancers; these diseases are characterized by aberrant integrins-regulated cell migration.</text>
</comment>
<comment type="catalytic activity">
<text evidence="10">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="32 33 36 41 42 44 47">Repressed by 4-(3-hydroxyanilino)-quinolines derivatives, indolin-2-one-derivatives, 2-(alkylsulfanyl)-4-(3-thienyl) nicotinonitrile analogs, 3- and 4-substituted beta-carbolin-1-ones, vandetanib, motesanib, sorafenib (BAY 43-9006), cabozantinib (XL184), sunitinib, and withaferin A (WA). Inactivation by sorafenib both reduces kinase activity and promotes lysosomal degradation.</text>
</comment>
<comment type="subunit">
<text evidence="29 35 37 41 48 49">Phosphorylated form interacts with the PBT domain of DOK2, DOK4 and DOK5. The phosphorylated form interacts with PLCG1 and GRB7. Interacts (not phosphorylated) with PTK2/FAK1 (via FERM domain). Extracellular cell-membrane anchored RET cadherin fragments form complex in neurons with reduced trophic status, preferentially at the contact sites between somas. Interacts with AIP in the pituitary gland; this interaction prevents the formation of the AIP-survivin complex. Binds to ARTN. Interacts (inactive) with CBLC and CD2AP; dissociates upon activation by GDNF which increases CBLC:CD2AP interaction.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2480756"/>
<interactant intactId="EBI-945833">
<id>Q7Z3S9</id>
<label>NOTCH2NL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2480756"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2480756"/>
<interactant intactId="EBI-7395583">
<id>Q62985</id>
<label>Sh2b1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2480756"/>
<interactant intactId="EBI-518675">
<id>P40763</id>
<label>STAT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="38">Cell membrane</location>
<topology evidence="38">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="38">Endosome membrane</location>
<topology evidence="38">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P07949-1</id>
<name>1</name>
<name>RET51</name>
<sequence type="displayed"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P07949-2</id>
<name>2</name>
<name>RET9</name>
<sequence type="described" ref="VSP_040735"/>
</isoform>
</comment>
<comment type="induction">
<text evidence="39">Positively regulated by NKX2-1, PHOX2B, SOX10 and PAX3.</text>
</comment>
<comment type="PTM">
<text evidence="20 26 28 29 41">Autophosphorylated on C-terminal tyrosine residues upon ligand stimulation. Dephosphorylated by PTPRJ on Tyr-905, Tyr-1015 and Tyr-1062.</text>
</comment>
<comment type="PTM">
<text evidence="48">Proteolytically cleaved by caspase-3. The soluble RET kinase fragment is able to induce cell death. The extracellular cell-membrane anchored RET cadherin fragment accelerates cell adhesion in sympathetic neurons.</text>
</comment>
<comment type="polymorphism">
<text>The Cys-982 polymorphism may be associated with an increased risk for developing Hirschsprung disease.</text>
</comment>
<comment type="disease">
<disease id="DI-01359">
<name>Colorectal cancer</name>
<acronym>CRC</acronym>
<description>A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history.</description>
<dbReference type="MIM" id="114500"/>
</disease>
<text>The disease may be caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="11 14 17 50 54 55 56 62 69 70 76 77 78 81 84 93">
<disease id="DI-01746">
<name>Hirschsprung disease 1</name>
<acronym>HSCR1</acronym>
<description>A disorder of neural crest development characterized by absence of enteric ganglia along a variable length of the intestine. It is the most common cause of congenital intestinal obstruction. Early symptoms range from complete acute neonatal obstruction, characterized by vomiting, abdominal distention and failure to pass stool, to chronic constipation in the older child.</description>
<dbReference type="MIM" id="142623"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="12 18 21 57 58 59 61 62 66 68 71 73 75 80 81 85 87 89 90 91">
<disease id="DI-01957">
<name>Medullary thyroid carcinoma</name>
<acronym>MTC</acronym>
<description>Rare tumor derived from the C cells of the thyroid. Three hereditary forms are known, that are transmitted in an autosomal dominant fashion: (a) multiple neoplasia type 2A (MEN2A), (b) multiple neoplasia type IIB (MEN2B) and (c) familial MTC (FMTC), which occurs in 25-30% of MTC cases and where MTC is the only clinical manifestation.</description>
<dbReference type="MIM" id="155240"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="63 64 65 72 75 82 83">
<disease id="DI-02009">
<name>Multiple neoplasia 2B</name>
<acronym>MEN2B</acronym>
<description>Uncommon inherited cancer syndrome characterized by predisposition to MTC and phaeochromocytoma which is associated with marfanoid habitus, mucosal neuromas, skeletal and ophthalmic abnormalities, and ganglioneuromas of the intestine tract. Then the disease progresses rapidly with the development of metastatic MTC and a pheochromocytome in 50% of cases.</description>
<dbReference type="MIM" id="162300"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="22">
<disease id="DI-02160">
<name>Pheochromocytoma</name>
<acronym>PCC</acronym>
<description>A catecholamine-producing tumor of chromaffin tissue of the adrenal medulla or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of epinephrine and norepinephrine, is hypertension, which may be persistent or intermittent.</description>
<dbReference type="MIM" id="171300"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="15 60 61 62 66 67 68 74 75 79 84 86">
<disease id="DI-02008">
<name>Multiple neoplasia 2A</name>
<acronym>MEN2A</acronym>
<description>The most frequent form of medullary thyroid cancer (MTC). It is an inherited cancer syndrome characterized by MTC, phaeochromocytoma and/or hyperparathyroidism.</description>
<dbReference type="MIM" id="171400"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="13 19 24 51 52 53">Various chromosomal aberrations involving RET are known. Some of them have been found in papillary thyroid carcinomas (PTCs) (PubMed:12787916, PubMed:2406025, PubMed:10980597, PubMed:10439047). Inversion inv(10)(q11.2;q21) generates the RET/CCDC6 (PTC1) oncogene (PubMed:2406025). Inversion inv(10)(q11.2;q11.2) generates the RET/NCOA4 (PTC3) oncogene. Translocation t(10;14)(q11;q32) with GOLGA5 generates the RET/GOLGA5 (PTC5) oncogene (PubMed:2734021). Translocation t(8;10)(p21.3;q11.2) with PCM1 generates the PCM1/RET fusion (PubMed:10980597). Translocation t(6;10)(p21.3;q11.2) with TRIM27/RFP generates the Delta RFP/RET oncogene (PubMed:12787916). Translocation t(1;10)(p13;q11) with TRIM33 generates the TRIM33/RET (PTC7) oncogene (PubMed:10439047). Translocation t(7;10)(q32;q11) with TRIM24/TIF1 generates the TRIM24/RET (PTC6) oncogene (PubMed:10439047). Translocation t(6;10)(p21.3;q11.2) with TRIM27/RFP generates the TRIM27/RET oncogene (PubMed:3037315).</text>
</comment>
<comment type="disease">
<text>Mutations in RET have been detected in patients with renal agenesis suggesting a possible involvement of this gene in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="23 25 88">
<disease id="DI-01391">
<name>Congenital central hypoventilation syndrome</name>
<acronym>CCHS</acronym>
<description>Rare disorder characterized by abnormal control of respiration in the absence of neuromuscular or lung disease, or an identifiable brain stem lesion. A deficiency in autonomic control of respiration results in inadequate or negligible ventilatory and arousal responses to hypercapnia and hypoxemia.</description>
<dbReference type="MIM" id="209880"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Treatment with withaferin A (WA) leads tumor regression in medullary thyroid carcinomas (MTC).</text>
</comment>
<comment type="similarity">
<text evidence="9">Belongs to the protein kinase superfamily. Tyr protein kinase family.</text>
</comment>
<comment type="sequence caution" evidence="97">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAA36524" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="sequence caution" evidence="97">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAA36786" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="sequence caution" evidence="97">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAA33787" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="sequence caution" evidence="97">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAC14882" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/RETID76.html"/>
</comment>
<comment type="online information" name="MEN2 RET database">
<link uri="http://www.arup.utah.edu/database/MEN2/MEN2_welcome.php"/>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="AK291807">
<property type="protein sequence ID" value="BAF84496.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC010864">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC004257">
<property type="protein sequence ID" value="AAH04257.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X15262">
<property type="protein sequence ID" value="CAA33333.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X12949">
<property type="protein sequence ID" value="CAA31408.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M16029">
<property type="protein sequence ID" value="AAA36786.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X15786">
<property type="protein sequence ID" value="CAA33787.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M31213">
<property type="protein sequence ID" value="AAA36524.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ297349">
<property type="protein sequence ID" value="CAC14882.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53525.1">
<molecule id="P07949-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7200.1">
<molecule id="P07949-1"/>
</dbReference>
<dbReference type="PIR" id="A27203">
<property type="entry name" value="TVHURE"/>
</dbReference>
<dbReference type="PIR" id="A34630">
<property type="entry name" value="A34630"/>
</dbReference>
<dbReference type="PIR" id="B34735">
<property type="entry name" value="B34735"/>
</dbReference>
<dbReference type="PIR" id="S05582">
<property type="entry name" value="S05582"/>
</dbReference>
<dbReference type="RefSeq" id="NP_065681.1">
<molecule id="P07949-2"/>
<property type="nucleotide sequence ID" value="NM_020630.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_066124.1">
<molecule id="P07949-1"/>
<property type="nucleotide sequence ID" value="NM_020975.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.350321"/>
<dbReference type="PDB" id="1XPD">
<property type="method" value="Model"/>
<property type="chains" value="A=709-1013"/>
</dbReference>
<dbReference type="PDB" id="2IVS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=705-1013"/>
</dbReference>
<dbReference type="PDB" id="2IVT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=705-1013"/>
</dbReference>
<dbReference type="PDB" id="2IVU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=705-1013"/>
</dbReference>
<dbReference type="PDB" id="2IVV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=705-1013"/>
</dbReference>
<dbReference type="PDB" id="2X2K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=705-1013"/>
</dbReference>
<dbReference type="PDB" id="2X2L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=705-1013"/>
</dbReference>
<dbReference type="PDB" id="2X2M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=705-1013"/>
</dbReference>
<dbReference type="PDB" id="2X2U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=29-270"/>
</dbReference>
<dbReference type="PDB" id="4CKI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A=705-1013"/>
</dbReference>
<dbReference type="PDB" id="4CKJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=705-1013"/>
</dbReference>
<dbReference type="PDB" id="4UX8">
<property type="method" value="EM"/>
<property type="resolution" value="24.00"/>
<property type="chains" value="A/B=29-635"/>
</dbReference>
<dbReference type="PDB" id="5AMN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.57"/>
<property type="chains" value="A=705-1012"/>
</dbReference>
<dbReference type="PDB" id="5FM2">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=659-1013"/>
</dbReference>
<dbReference type="PDB" id="5FM3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=659-1013"/>
</dbReference>
<dbReference type="PDBsum" id="1XPD"/>
<dbReference type="PDBsum" id="2IVS"/>
<dbReference type="PDBsum" id="2IVT"/>
<dbReference type="PDBsum" id="2IVU"/>
<dbReference type="PDBsum" id="2IVV"/>
<dbReference type="PDBsum" id="2X2K"/>
<dbReference type="PDBsum" id="2X2L"/>
<dbReference type="PDBsum" id="2X2M"/>
<dbReference type="PDBsum" id="2X2U"/>
<dbReference type="PDBsum" id="4CKI"/>
<dbReference type="PDBsum" id="4CKJ"/>
<dbReference type="PDBsum" id="4UX8"/>
<dbReference type="PDBsum" id="5AMN"/>
<dbReference type="PDBsum" id="5FM2"/>
<dbReference type="PDBsum" id="5FM3"/>
<dbReference type="ProteinModelPortal" id="P07949"/>
<dbReference type="SMR" id="P07949"/>
<dbReference type="BioGrid" id="111911">
<property type="interactions" value="43"/>
</dbReference>
<dbReference type="DIP" id="DIP-41449N"/>
<dbReference type="IntAct" id="P07949">
<property type="interactions" value="29"/>
</dbReference>
<dbReference type="MINT" id="MINT-1217685"/>
<dbReference type="STRING" id="9606.ENSP00000347942"/>
<dbReference type="BindingDB" id="P07949"/>
<dbReference type="ChEMBL" id="CHEMBL2041"/>
<dbReference type="DrugBank" id="DB08764">
<property type="generic name" value="4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB08875">
<property type="generic name" value="Cabozantinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05216">
<property type="generic name" value="MP470"/>
</dbReference>
<dbReference type="DrugBank" id="DB08901">
<property type="generic name" value="Ponatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00398">
<property type="generic name" value="Sorafenib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2185"/>
<dbReference type="iPTMnet" id="P07949"/>
<dbReference type="PhosphoSitePlus" id="P07949"/>
<dbReference type="BioMuta" id="RET"/>
<dbReference type="DMDM" id="547807"/>
<dbReference type="EPD" id="P07949"/>
<dbReference type="MaxQB" id="P07949"/>
<dbReference type="PaxDb" id="P07949"/>
<dbReference type="PeptideAtlas" id="P07949"/>
<dbReference type="PRIDE" id="P07949"/>
<dbReference type="TopDownProteomics" id="P07949-2">
<molecule id="P07949-2"/>
</dbReference>
<dbReference type="DNASU" id="5979"/>
<dbReference type="Ensembl" id="ENST00000340058">
<molecule id="P07949-2"/>
<property type="protein sequence ID" value="ENSP00000344798"/>
<property type="gene ID" value="ENSG00000165731"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000355710">
<molecule id="P07949-1"/>
<property type="protein sequence ID" value="ENSP00000347942"/>
<property type="gene ID" value="ENSG00000165731"/>
</dbReference>
<dbReference type="GeneID" id="5979"/>
<dbReference type="KEGG" id="hsa:5979"/>
<dbReference type="UCSC" id="uc001jak.2">
<molecule id="P07949-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5979"/>
<dbReference type="DisGeNET" id="5979"/>
<dbReference type="GeneCards" id="RET"/>
<dbReference type="GeneReviews" id="RET"/>
<dbReference type="HGNC" id="HGNC:9967">
<property type="gene designation" value="RET"/>
</dbReference>
<dbReference type="HPA" id="CAB002581"/>
<dbReference type="HPA" id="CAB018342"/>
<dbReference type="HPA" id="HPA008356"/>
<dbReference type="HPA" id="HPA008495"/>
<dbReference type="MalaCards" id="RET"/>
<dbReference type="MIM" id="114500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="142623">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="155240">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="162300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="164761">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="171300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="171400">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="209880">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P07949"/>
<dbReference type="OpenTargets" id="ENSG00000165731"/>
<dbReference type="Orphanet" id="1848">
<property type="disease" value="Bilateral renal agenesis"/>
</dbReference>
<dbReference type="Orphanet" id="99361">
<property type="disease" value="Familial medullary thyroid carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="99803">
<property type="disease" value="Haddad syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="29072">
<property type="disease" value="Hereditary pheochromocytoma-paraganglioma"/>
</dbReference>
<dbReference type="Orphanet" id="388">
<property type="disease" value="Hirschsprung disease"/>
</dbReference>
<dbReference type="Orphanet" id="247698">
<property type="disease" value="Multiple endocrine neoplasia type 2A"/>
</dbReference>
<dbReference type="Orphanet" id="247709">
<property type="disease" value="Multiple endocrine neoplasia type 2B"/>
</dbReference>
<dbReference type="Orphanet" id="146">
<property type="disease" value="Papillary or follicular thyroid carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="93100">
<property type="disease" value="Unilateral renal agenesis"/>
</dbReference>
<dbReference type="PharmGKB" id="PA34335"/>
<dbReference type="eggNOG" id="KOG0200">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118923"/>
<dbReference type="HOGENOM" id="HOG000010301"/>
<dbReference type="HOVERGEN" id="HBG002609"/>
<dbReference type="InParanoid" id="P07949"/>
<dbReference type="KO" id="K05126"/>
<dbReference type="OMA" id="WRQGDGK"/>
<dbReference type="OrthoDB" id="EOG091G0CQZ"/>
<dbReference type="PhylomeDB" id="P07949"/>
<dbReference type="TreeFam" id="TF317640"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853659">
<property type="pathway name" value="RET signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P07949"/>
<dbReference type="SIGNOR" id="P07949"/>
<dbReference type="ChiTaRS" id="RET">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P07949"/>
<dbReference type="GeneWiki" id="RET_proto-oncogene"/>
<dbReference type="GenomeRNAi" id="5979"/>
<dbReference type="PRO" id="PR:P07949"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000165731"/>
<dbReference type="CleanEx" id="HS_RET"/>
<dbReference type="ExpressionAtlas" id="P07949">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P07949">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0098797">
<property type="term" value="C:plasma membrane protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="FlyBase"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004872">
<property type="term" value="F:receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006919">
<property type="term" value="P:activation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0071300">
<property type="term" value="P:cellular response to retinoic acid"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001838">
<property type="term" value="P:embryonic epithelial tube formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048484">
<property type="term" value="P:enteric nervous system development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007156">
<property type="term" value="P:homophilic cell adhesion via plasma membrane adhesion molecules"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0060384">
<property type="term" value="P:innervation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097021">
<property type="term" value="P:lymphocyte migration into lymphoid organs"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033619">
<property type="term" value="P:membrane protein proteolysis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001755">
<property type="term" value="P:neural crest cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007158">
<property type="term" value="P:neuron cell-cell adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042551">
<property type="term" value="P:neuron maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061146">
<property type="term" value="P:Peyer's patch morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033630">
<property type="term" value="P:positive regulation of cell adhesion mediated by integrin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045793">
<property type="term" value="P:positive regulation of cell size"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2001241">
<property type="term" value="P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072300">
<property type="term" value="P:positive regulation of metanephric glomerulus development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014042">
<property type="term" value="P:positive regulation of neuron maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010976">
<property type="term" value="P:positive regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903263">
<property type="term" value="P:positive regulation of serine phosphorylation of STAT3 protein"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007497">
<property type="term" value="P:posterior midgut development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0050770">
<property type="term" value="P:regulation of axonogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030155">
<property type="term" value="P:regulation of cell adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048265">
<property type="term" value="P:response to pain"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060041">
<property type="term" value="P:retina development in camera-type eye"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035799">
<property type="term" value="P:ureter maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001657">
<property type="term" value="P:ureteric bud development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR002126">
<property type="entry name" value="Cadherin"/>
</dbReference>
<dbReference type="InterPro" id="IPR015919">
<property type="entry name" value="Cadherin-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016249">
<property type="entry name" value="Tyr_kinase_Ret_rcpt"/>
</dbReference>
<dbReference type="Pfam" id="PF00028">
<property type="entry name" value="Cadherin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000631">
<property type="entry name" value="TyrPK_receptor_Ret"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49313">
<property type="entry name" value="SSF49313"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50268">
<property type="entry name" value="CADHERIN_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0130">Cell adhesion</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0367">Hirschsprung disease</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<feature type="signal peptide" evidence="7">
<location>
<begin position="1"/>
<end position="28"/>
</location>
</feature>
<feature type="chain" description="Proto-oncogene tyrosine-protein kinase receptor Ret" id="PRO_0000024450">
<location>
<begin position="29"/>
<end position="1114"/>
</location>
</feature>
<feature type="chain" description="Extracellular cell-membrane anchored RET cadherin 120 kDa fragment" id="PRO_0000415292">
<location>
<begin position="29"/>
<end position="707"/>
</location>
</feature>
<feature type="chain" description="Soluble RET kinase fragment" id="PRO_0000415293">
<location>
<begin position="708"/>
<end position="1017"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="7">
<location>
<begin position="29"/>
<end position="635"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="7">
<location>
<begin position="636"/>
<end position="657"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="7">
<location>
<begin position="658"/>
<end position="1114"/>
</location>
</feature>
<feature type="domain" description="Cadherin" evidence="8">
<location>
<begin position="168"/>
<end position="272"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="9">
<location>
<begin position="724"/>
<end position="1016"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="9">
<location>
<begin position="730"/>
<end position="738"/>
</location>
</feature>
<feature type="region of interest" description="Inhibitors binding">
<location>
<begin position="805"/>
<end position="807"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="9 10">
<location>
<position position="874"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="9">
<location>
<position position="758"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor">
<location>
<position position="892"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form the TRIM27/RET oncogene">
<location>
<begin position="587"/>
<end position="588"/>
</location>
</feature>
<feature type="site" description="Cleavage; by caspase-3">
<location>
<begin position="707"/>
<end position="708"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form PCM1-RET; RET-CCDC6; RET-GOLGA5; RET-TRIM24 and RET-TRIM33 oncogenes">
<location>
<begin position="712"/>
<end position="713"/>
</location>
</feature>
<feature type="site" description="Cleavage; by caspase-3">
<location>
<begin position="1017"/>
<end position="1018"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="696"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26">
<location>
<position position="806"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26">
<location>
<position position="809"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26 29">
<location>
<position position="900"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26 28 29 41">
<location>
<position position="905"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26">
<location>
<position position="981"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="20 26 28">
<location>
<position position="1015"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="20 26 28">
<location>
<position position="1062"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26">
<location>
<position position="1090"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26">
<location>
<position position="1096"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="98"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="43">
<location>
<position position="151"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="336"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="343"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="361"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="367"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="377"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="394"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="448"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="468"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="554"/>
</location>
</feature>
<feature type="disulfide bond" evidence="43">
<location>
<begin position="137"/>
<end position="142"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_040735" evidence="94 95 96">
<original>MSDPNWPGESPVPLTRADGTNTGFPRYPNDSVYANWMLSPSAAKLMDTFDS</original>
<variation>RISHAFTRF</variation>
<location>
<begin position="1064"/>
<end position="1114"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_009459" evidence="55">
<original>P</original>
<variation>L</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; familial form; dbSNP:rs76764689." id="VAR_006295" evidence="17 70">
<original>S</original>
<variation>L</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_009492" evidence="56 76">
<original>L</original>
<variation>P</variation>
<location>
<position position="40"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; familial form; dbSNP:rs77596424." id="VAR_006296" evidence="70">
<original>P</original>
<variation>L</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In CCHS; dbSNP:rs192489011." id="VAR_018153" evidence="25">
<original>R</original>
<variation>H</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_009460" evidence="17">
<original>R</original>
<variation>C</variation>
<location>
<position position="77"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; unknown pathological significance." id="VAR_006297" evidence="55">
<original>G</original>
<variation>S</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs747483905." id="VAR_067101" evidence="50">
<original>R</original>
<variation>C</variation>
<location>
<position position="114"/>
</location>
</feature>
<feature type="sequence variant" description="In CCHS and HSCR1; dbSNP:rs76397662." id="VAR_018154" evidence="23 25 50">
<original>R</original>
<variation>H</variation>
<location>
<position position="114"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_006298">
<original>C</original>
<variation>S</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; also in a colorectal cancer sample; somatic mutation." id="VAR_035711" evidence="30 50">
<original>V</original>
<variation>G</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_067102" evidence="50">
<original>P</original>
<variation>L</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; unknown pathological significance." id="VAR_009461" evidence="93">
<original>C</original>
<variation>Y</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs149403911." id="VAR_041762" evidence="31">
<original>R</original>
<variation>Q</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_009462" evidence="78">
<original>F</original>
<variation>S</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_067103" evidence="50">
<original>R</original>
<variation>P</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_009463" evidence="77">
<original>R</original>
<variation>P</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_009464" evidence="78">
<original>C</original>
<variation>Y</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with renal agenesis; unknown pathological significance; prevents phosphorylation in response to GDNF; dbSNP:rs76736111." id="VAR_044392" evidence="34">
<original>P</original>
<variation>T</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; familial form; dbSNP:rs79661516." id="VAR_006299">
<original>R</original>
<variation>H</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; familial form; dbSNP:rs562449603." id="VAR_006300">
<original>E</original>
<variation>K</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs541929171." id="VAR_067104" evidence="50">
<original>T</original>
<variation>A</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="Found in two patients with Hirschsprung disease; dbSNP:rs35118262." id="VAR_041763" evidence="31 50">
<original>T</original>
<variation>N</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_067105" evidence="50">
<original>T</original>
<variation>P</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_006301">
<original>R</original>
<variation>Q</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with Hirschsprung disease; unknown pathological significance; dbSNP:rs34682185." id="VAR_041764" evidence="31 50">
<original>V</original>
<variation>M</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_067106" evidence="50">
<original>D</original>
<variation>N</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs77702891." id="VAR_009465" evidence="50 77">
<original>R</original>
<variation>Q</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_067107" evidence="50">
<original>S</original>
<variation>I</variation>
<location>
<position position="316"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs80236571." id="VAR_006302" evidence="55 70">
<original>R</original>
<variation>Q</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs774829203." id="VAR_067108" evidence="50">
<original>S</original>
<variation>L</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_067109" evidence="50">
<original>D</original>
<variation>Y</variation>
<location>
<position position="353"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; unknown pathological significance." id="VAR_009466" evidence="93">
<original>N</original>
<variation>K</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs762472027." id="VAR_067110" evidence="50">
<original>R</original>
<variation>Q</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_009467" evidence="17 30">
<original>R</original>
<variation>W</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with renal agenesis; unknown pathological significance; constitutively phosphorylated; expressed only the immature intracellular form." id="VAR_044393" evidence="34">
<original>V</original>
<variation>A</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; familial form; dbSNP:rs78098482." id="VAR_006303" evidence="70">
<original>F</original>
<variation>L</variation>
<location>
<position position="393"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with renal agenesis; unknown pathological significance; prevents phosphorylation in response to GDNF." id="VAR_044394" evidence="34">
<original>N</original>
<variation>H</variation>
<location>
<position position="394"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_009468" evidence="17">
<original>N</original>
<variation>K</variation>
<location>
<position position="394"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs183729115." id="VAR_067111" evidence="50">
<original>V</original>
<variation>M</variation>
<location>
<position position="397"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_006304" evidence="56">
<original>P</original>
<variation>L</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs746970700." id="VAR_067112" evidence="50">
<original>V</original>
<variation>M</variation>
<location>
<position position="412"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs767601598." id="VAR_067113" evidence="50">
<original>G</original>
<variation>R</variation>
<location>
<position position="423"/>
</location>
</feature>
<feature type="sequence variant" description="In CCHS; dbSNP:rs552057730." id="VAR_018155" evidence="25">
<original>A</original>
<variation>E</variation>
<location>
<position position="432"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form; dbSNP:rs138624658." id="VAR_006305">
<original>R</original>
<variation>Q</variation>
<location>
<position position="475"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs537874538." id="VAR_067114" evidence="50">
<original>E</original>
<variation>K</variation>
<location>
<position position="480"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9282834." id="VAR_018156" evidence="25 31">
<original>D</original>
<variation>N</variation>
<location>
<position position="489"/>
</location>
</feature>
<feature type="sequence variant" description="In MTC; familial form." id="VAR_009469" evidence="12">
<original>C</original>
<variation>CEEC</variation>
<location>
<position position="531"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_067115" evidence="50">
<location>
<begin position="549"/>
<end position="550"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation." id="VAR_035712" evidence="30">
<original>G</original>
<variation>E</variation>
<location>
<position position="593"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_067116" evidence="50">
<original>E</original>
<variation>Q</variation>
<location>
<position position="595"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs377767393." id="VAR_008966" evidence="16">
<original>R</original>
<variation>Q</variation>
<location>
<position position="600"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A; dbSNP:rs77558292." id="VAR_009470">
<original>C</original>
<variation>G</variation>
<location>
<position position="609"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A; dbSNP:rs77558292." id="VAR_009471">
<original>C</original>
<variation>R</variation>
<location>
<position position="609"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; familial form; dbSNP:rs377767396." id="VAR_006307" evidence="62">
<original>C</original>
<variation>W</variation>
<location>
<position position="609"/>
</location>
</feature>
<feature type="sequence variant" description="In MTC, MEN2A and HSCR1; familial and sporadic forms; dbSNP:rs77939446." id="VAR_006306" evidence="55 59 84 93">
<original>C</original>
<variation>Y</variation>
<location>
<position position="609"/>
</location>
</feature>
<feature type="sequence variant" description="In MTC; familial form; dbSNP:rs377767391." id="VAR_009472" evidence="91">
<original>C</original>
<variation>G</variation>
<location>
<position position="611"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A; dbSNP:rs377767391." id="VAR_009473">
<original>C</original>
<variation>R</variation>
<location>
<position position="611"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A; dbSNP:rs377767391." id="VAR_009474">
<original>C</original>
<variation>S</variation>
<location>
<position position="611"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A and MTC; familial form; dbSNP:rs80069458." id="VAR_006308" evidence="68">
<original>C</original>
<variation>W</variation>
<location>
<position position="611"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A; dbSNP:rs377767397." id="VAR_006309">
<original>C</original>
<variation>Y</variation>
<location>
<position position="611"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A and MTC; familial form; dbSNP:rs79781594." id="VAR_006312">
<original>C</original>
<variation>F</variation>
<location>
<position position="618"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A; dbSNP:rs76262710." id="VAR_006310" evidence="67">
<original>C</original>
<variation>G</variation>
<location>
<position position="618"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A, MTC and HSCR1; dbSNP:rs76262710." id="VAR_006311" evidence="59 62 66 81">
<original>C</original>
<variation>R</variation>
<location>
<position position="618"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A, HSCR1 and MTC; familial and sporadic forms; dbSNP:rs79781594." id="VAR_006313" evidence="59 60 66 68 84">
<original>C</original>
<variation>S</variation>
<location>
<position position="618"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A and MTC; familial form; dbSNP:rs79781594." id="VAR_006314">
<original>C</original>
<variation>Y</variation>
<location>
<position position="618"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A and MTC; familial form; dbSNP:rs77503355." id="VAR_006318" evidence="66">
<original>C</original>
<variation>F</variation>
<location>
<position position="620"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A and MTC; familial and sporadic forms; dbSNP:rs77316810." id="VAR_006315">
<original>C</original>
<variation>G</variation>
<location>
<position position="620"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A, MTC and HSCR1; familial and sporadic forms; dbSNP:rs77316810." id="VAR_006316" evidence="55 62 66 68 77 84 93">
<original>C</original>
<variation>R</variation>
<location>
<position position="620"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A and MTC; familial form; dbSNP:rs77503355." id="VAR_006317" evidence="59 60">
<original>C</original>
<variation>S</variation>
<location>
<position position="620"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A and HSCR1; dbSNP:rs79890926." id="VAR_009475" evidence="84">
<original>C</original>
<variation>W</variation>
<location>
<position position="620"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A; dbSNP:rs77503355." id="VAR_006319" evidence="68">
<original>C</original>
<variation>Y</variation>
<location>
<position position="620"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_009476" evidence="11">
<original>Q</original>
<variation>K</variation>
<location>
<position position="626"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A and MTC; familial form; dbSNP:rs377767405." id="VAR_006320">
<original>C</original>
<variation>F</variation>
<location>
<position position="630"/>
</location>
</feature>
<feature type="sequence variant" description="In MTC; sporadic form; dbSNP:rs377767405." id="VAR_009477">
<original>C</original>
<variation>S</variation>
<location>
<position position="630"/>
</location>
</feature>
<feature type="sequence variant" description="In MTC; familial and sporadic forms; dbSNP:rs377767405." id="VAR_009478">
<original>C</original>
<variation>Y</variation>
<location>
<position position="630"/>
</location>
</feature>
<feature type="sequence variant" description="In thyroid carcinoma; somatic mutation; dbSNP:rs121913308." id="VAR_006321">
<original>D</original>
<variation>G</variation>
<location>
<position position="631"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A; dbSNP:rs377767408." id="VAR_006322">
<original>ELC</original>
<variation>DVR</variation>
<location>
<begin position="632"/>
<end position="634"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A." id="VAR_006329">
<original>CR</original>
<variation>WG</variation>
<location>
<begin position="634"/>
<end position="635"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A." id="VAR_009479" evidence="79">
<original>C</original>
<variation>CHELC</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A and pheochromocytoma; dbSNP:rs75996173." id="VAR_006324" evidence="22 66 67">
<original>C</original>
<variation>F</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A and pheochromocytoma; dbSNP:rs75076352." id="VAR_006323" evidence="22 66 67">
<original>C</original>
<variation>G</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A, pheochromocytoma and MTC; familial form; also found as somatic mutation in a sporadic thyroid carcinoma; dbSNP:rs75076352." id="VAR_006326" evidence="22 60 68">
<original>C</original>
<variation>R</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A, pheochromocytoma and MTC; familial form; dbSNP:rs75076352." id="VAR_006327" evidence="22 67">
<original>C</original>
<variation>S</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A, pheochromocytoma and MTC; familial form; dbSNP:rs77709286." id="VAR_006328" evidence="22">
<original>C</original>
<variation>W</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A, pheochromocytoma and MTC; familial form; dbSNP:rs75996173." id="VAR_006325" evidence="22 60 66 67">
<original>C</original>
<variation>Y</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A." id="VAR_006330" evidence="86">
<original>T</original>
<variation>TCRT</variation>
<location>
<position position="636"/>
</location>
</feature>
<feature type="sequence variant" description="In MTC; sporadic form." id="VAR_012743" evidence="21">
<original>A</original>
<variation>G</variation>
<location>
<position position="639"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A; dbSNP:rs78935588." id="VAR_009480" evidence="15">
<original>A</original>
<variation>G</variation>
<location>
<position position="640"/>
</location>
</feature>
<feature type="sequence variant" description="In MTC; sporadic form." id="VAR_012744" evidence="21">
<original>A</original>
<variation>G</variation>
<location>
<position position="641"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_067117" evidence="50">
<original>P</original>
<variation>L</variation>
<location>
<position position="679"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_006331">
<original>S</original>
<variation>P</variation>
<location>
<position position="690"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1799939." id="VAR_006332" evidence="25 31 80 88">
<original>G</original>
<variation>S</variation>
<location>
<position position="691"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs141185224." id="VAR_067118" evidence="50">
<original>R</original>
<variation>Q</variation>
<location>
<position position="694"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34288963." id="VAR_041765" evidence="31">
<original>R</original>
<variation>T</variation>
<location>
<position position="749"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_009481" evidence="56">
<original>E</original>
<variation>Q</variation>
<location>
<position position="762"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs75075748." id="VAR_009493" evidence="56 69 76">
<original>S</original>
<variation>P</variation>
<location>
<position position="765"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_006334">
<original>S</original>
<variation>R</variation>
<location>
<position position="767"/>
</location>
</feature>
<feature type="sequence variant" description="In MTC; familial and sporadic forms; dbSNP:rs78014899." id="VAR_006335" evidence="57 58 75">
<original>E</original>
<variation>D</variation>
<location>
<position position="768"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with renal agenesis; unknown pathological significance; constitutively phosphorylated; dbSNP:rs75686697." id="VAR_044395" evidence="34">
<original>V</original>
<variation>I</variation>
<location>
<position position="778"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs587778656." id="VAR_067119" evidence="50">
<original>N</original>
<variation>S</variation>
<location>
<position position="783"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2A and MTC; familial form; dbSNP:rs75030001." id="VAR_009482" evidence="89">
<original>L</original>
<variation>F</variation>
<location>
<position position="790"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1, pheochromocytoma, MTC and MEN2A; familial form; dbSNP:rs77724903." id="VAR_009483" evidence="22 77 89">
<original>Y</original>
<variation>F</variation>
<location>
<position position="791"/>
</location>
</feature>
<feature type="sequence variant" description="In MTC; familial form; dbSNP:rs79658334." id="VAR_006336" evidence="57">
<original>V</original>
<variation>L</variation>
<location>
<position position="804"/>
</location>
</feature>
<feature type="sequence variant" description="In MTC; familial form; dbSNP:rs79658334." id="VAR_006337" evidence="18 87">
<original>V</original>
<variation>M</variation>
<location>
<position position="804"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_009484" evidence="11">
<original>R</original>
<variation>Q</variation>
<location>
<position position="813"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34617196." id="VAR_041766" evidence="31">
<original>Y</original>
<variation>S</variation>
<location>
<position position="826"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs200127630." id="VAR_067120" evidence="50">
<original>G</original>
<variation>R</variation>
<location>
<position position="830"/>
</location>
</feature>
<feature type="sequence variant" description="In MTC; familial form; dbSNP:rs55947360." id="VAR_011582" evidence="18 31">
<original>R</original>
<variation>L</variation>
<location>
<position position="844"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_006338">
<original>R</original>
<variation>Q</variation>
<location>
<position position="873"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2B; somatic mutation in sporadic medullary thyroid carcinoma; requires 2 nucleotide substitutions; dbSNP:rs377767429." id="VAR_009485" evidence="82 83">
<original>A</original>
<variation>F</variation>
<location>
<position position="883"/>
</location>
</feature>
<feature type="sequence variant" description="In MTC; familial form; dbSNP:rs75234356." id="VAR_009486" evidence="85">
<original>S</original>
<variation>A</variation>
<location>
<position position="891"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_006339">
<original>F</original>
<variation>L</variation>
<location>
<position position="893"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with renal agenesis; unknown pathological significance; constitutively phosphorylated; expressed only the immature intracellular form." id="VAR_044396" evidence="34">
<original>G</original>
<variation>S</variation>
<location>
<position position="894"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form; dbSNP:rs76087194." id="VAR_006340" evidence="56 69">
<original>R</original>
<variation>Q</variation>
<location>
<position position="897"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form; dbSNP:rs377767430." id="VAR_006341">
<original>K</original>
<variation>E</variation>
<location>
<position position="907"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_067121" evidence="50">
<original>K</original>
<variation>T</variation>
<location>
<position position="907"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2B and MTC; sporadic form; somatic mutation; also found in a patient with renal agenesis; dbSNP:rs74799832." id="VAR_006342" evidence="34 63 64 65 72 75">
<original>M</original>
<variation>T</variation>
<location>
<position position="918"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_006343">
<original>E</original>
<variation>K</variation>
<location>
<position position="921"/>
</location>
</feature>
<feature type="sequence variant" description="In MTC; sporadic form; dbSNP:rs377767432." id="VAR_012745" evidence="21">
<original>S</original>
<variation>F</variation>
<location>
<position position="922"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs377767432." id="VAR_009487" evidence="72">
<original>S</original>
<variation>Y</variation>
<location>
<position position="922"/>
</location>
</feature>
<feature type="sequence variant" description="In MEN2B and MTC; familial form." id="VAR_006345">
<original>T</original>
<variation>M</variation>
<location>
<position position="946"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_067122" evidence="50">
<original>F</original>
<variation>L</variation>
<location>
<position position="961"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; familial form; dbSNP:rs76534745." id="VAR_006346" evidence="56 69">
<original>R</original>
<variation>G</variation>
<location>
<position position="972"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; familial form." id="VAR_006347" evidence="56">
<original>P</original>
<variation>L</variation>
<location>
<position position="973"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; sporadic form." id="VAR_006348">
<original>M</original>
<variation>T</variation>
<location>
<position position="980"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17158558." id="VAR_006349" evidence="25 27 31 55 92">
<original>R</original>
<variation>C</variation>
<location>
<position position="982"/>
</location>
</feature>
<feature type="sequence variant" description="In CCHS; with colonic aganglionosis; dbSNP:rs79853121." id="VAR_018157" evidence="88">
<original>P</original>
<variation>L</variation>
<location>
<position position="1039"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs79853121." id="VAR_009488">
<original>P</original>
<variation>Q</variation>
<location>
<position position="1039"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with renal agenesis; unknown pathological significance; prevents phosphorylation in response to GDNF." id="VAR_044397" evidence="34">
<original>P</original>
<variation>L</variation>
<location>
<position position="1049"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_067123" evidence="50">
<original>L</original>
<variation>V</variation>
<location>
<position position="1052"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1." id="VAR_009489" evidence="14 93">
<location>
<position position="1059"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs536486113." id="VAR_009490" evidence="14 93">
<original>L</original>
<variation>P</variation>
<location>
<position position="1061"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; dbSNP:rs587778659." id="VAR_067124" evidence="50">
<original>Y</original>
<variation>C</variation>
<location>
<position position="1062"/>
</location>
</feature>
<feature type="sequence variant" description="In HSCR1; familial form; dbSNP:rs149513065." id="VAR_009491" evidence="50">
<original>M</original>
<variation>T</variation>
<location>
<position position="1064"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with renal agenesis; unknown pathological significance; prevents phosphorylation in response to GDNF; dbSNP:rs775583354." id="VAR_044398" evidence="34">
<original>P</original>
<variation>S</variation>
<location>
<position position="1067"/>
</location>
</feature>
<feature type="sequence variant" description="In a bladder transitional cell carcinoma sample; somatic mutation." id="VAR_041767" evidence="31">
<original>F</original>
<variation>Y</variation>
<location>
<position position="1112"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired cleavage by caspase-3 and loss of induced cell death." evidence="48">
<original>D</original>
<variation>N</variation>
<location>
<position position="707"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of induced cell death, but increased cell aggregation." evidence="48">
<location>
<begin position="708"/>
<end position="1114"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity. No effect on interaction with and dissociation from CBLC and CD2AP." evidence="35 48">
<original>K</original>
<variation>R</variation>
<location>
<position position="758"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAA36786." ref="6" evidence="97">
<original>I</original>
<variation>V</variation>
<location>
<position position="647"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAF84496." ref="1" evidence="97">
<original>A</original>
<variation>S</variation>
<location>
<position position="664"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; AAA36524." ref="9" evidence="97">
<original>A</original>
<variation>G</variation>
<location>
<position position="750"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAA36786." ref="6" evidence="97">
<original>S</original>
<variation>P</variation>
<location>
<position position="904"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="30"/>
<end position="32"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="34"/>
<end position="41"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="49"/>
<end position="52"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="70"/>
<end position="73"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="75"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="79"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="85"/>
<end position="88"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="90"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="94"/>
<end position="99"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="103"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="120"/>
<end position="126"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="139"/>
<end position="141"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="142"/>
<end position="152"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="157"/>
<end position="159"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="162"/>
<end position="166"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="174"/>
<end position="178"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="184"/>
<end position="187"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="191"/>
<end position="196"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="202"/>
<end position="208"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="212"/>
<end position="215"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="222"/>
<end position="227"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="231"/>
<end position="233"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="235"/>
<end position="245"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="252"/>
<end position="263"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="705"/>
<end position="711"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="715"/>
<end position="717"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="721"/>
<end position="723"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="724"/>
<end position="732"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="734"/>
<end position="744"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="746"/>
<end position="748"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="750"/>
<end position="760"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="766"/>
<end position="779"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="790"/>
<end position="794"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="796"/>
<end position="798"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="801"/>
<end position="805"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="812"/>
<end position="817"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="819"/>
<end position="821"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="844"/>
<end position="846"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="848"/>
<end position="867"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="877"/>
<end position="879"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="880"/>
<end position="883"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="884"/>
<end position="886"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="887"/>
<end position="890"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="893"/>
<end position="895"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="900"/>
<end position="902"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="915"/>
<end position="917"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="920"/>
<end position="925"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="930"/>
<end position="945"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="957"/>
<end position="959"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="960"/>
<end position="965"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="978"/>
<end position="987"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="992"/>
<end position="994"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="998"/>
<end position="1012"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2IVS"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2IVV"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2X2U"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4CKI"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4CKJ"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00043"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10090908"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10323403"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10439047"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10484767"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10522989"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10612852"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10618407"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10826520"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10980597"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11061555"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11692159"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12000816"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12086152"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12787916"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14566559"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14711813"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16778204"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16928683"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17664273"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17884497"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18252215"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18753381"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19053769"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19366855"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19823924"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19853745"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20064382"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20117004"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20409618"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20473317"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20605972"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20616503"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20702524"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21134556"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21357690"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21454698"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22174939"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2406025"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2734021"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3037315"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7581377"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7633441"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7704557"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7784092"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7845675"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7849720"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7860065"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7874109"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7881414"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7906417"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7906866"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7911697"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7915165"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8099202"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8103403"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8114938"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8114939"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8557249"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8595427"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8625130"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8626834"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8807338"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9043870"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9090527"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9094028"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9097963"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9223675"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9259198"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9294615"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9360560"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9384613"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9398735"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9452064"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9452077"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9497256"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9506724"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9621513"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9677065"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9760196"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000269">
<source ref="56"/>
</evidence>
<evidence key="94" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="95" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="96" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3037315"/>
</source>
</evidence>
<evidence key="97" type="ECO:0000305"/>
<sequence length="1114" mass="124319" checksum="A3DA0CE01A19A441" modified="1994-06-01" version="3" precursor="true">
MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAP
EEVPSFRLGQHLYGTYRTRLHENNWICIQEDTGLLYLNRSLDHSSWEKLSVRNRGFPLLT
VYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR
PPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELV
AVCTVHAGAREEVVMVPFPVTVYDEDDSAPTFPAGVDTASAVVEFKRKEDTVVATLRVFD
ADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR
NLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFA
QIGKVCVENCQAFSGINVQYKLHSSGANCSTLGVVTSAEDTSGILFVNDTKALRRPKCAE
LHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR
CEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPR
GIKAGYGTCNCFPEEEKCFCEPEDIQDPLCDELCRTVIAAAVLFSFIVSVLLSAFCIHCY
HKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP
RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK
QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH
PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY
EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL
FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRRDYLDLAA
STPSDSLIYDDGLSEEETPLVDCNNAPLPRALPSTWIENKLYGMSDPNWPGESPVPLTRA
DGTNTGFPRYPNDSVYANWMLSPSAAKLMDTFDS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>